Document:

Share Purchase Agreement, dated January 16, 2006

 Exhibit 4.5 
 CGEN DIGITAL MEDIA COMPANY LIMITED 
 SERIES B REDEEMABLE CONVERTIBLE PREFERRED SHARES

 PURCHASE AGREEMENT 
 (Sale by the Company of 
 Series B Redeemable Convertible Preferred Shares 
 Aggregate Sale Price US$10,000,000) 
 January 16, 2006 

 TABLE OF CONTENTS 
  

							
	 	  	Page
	 1.
	  	Terms of Purchase and Sale	  	1
				
		  	1.1  	  	Restated Articles	  	1
				
		  	1.2  	  	Purchase and Sale of Series B Shares	  	2
				
		  	1.3  	  	The Closing	  	2
				
		  	1.4  	  	Additional Closing(s)	  	2
			
	 2.
	  	Representations and Warranties of the Warrantors	  	3
				
		  	2.1  	  	Organization Good Standing and Qualification	  	3
				
		  	2.2  	  	Authorization	  	3
				
		  	2.3  	  	Capitalization, Share Incentive Plan	  	4
				
		  	2.4  	  	Subsidiaries	  	5
				
		  	2.5  	  	Compliance with Other Instruments	  	6
				
		  	2.6  	  	Consents	  	7
				
		  	2.7  	  	Permits	  	7
				
		  	2.8  	  	Litigation	  	7
				
		  	2.9  	  	Patents and Other Intangible Assets	  	7
				
		  	2.10	  	Marketing Rights	  	9
				
		  	2.11	  	Agreements, Action	  	10
				
		  	2.12	  	Brokers or Finders	  	11
				
		  	2.13	  	No Conflict of Interest	  	11
				
		  	2.14	  	Rights of Registration	  	12
				
		  	2.15	  	Corporate Documents and Minute Books	  	12
				
		  	2.16	  	Title to Property and Assets	  	12
				
		  	2.17	  	Financial Statements	  	13
				
		  	2.18	  	Changes	  	14
				
		  	2.19	  	Employment Benefit Plans	  	15
				
		  	2.20	  	Tax, Tax Returns and Payments	  	15
				
		  	2.21	  	Insurance	  	16
				
		  	2.22	  	Labor Agreements and Actions	  	16
				
		  	2.23	  	Environmental and Safety Laws	  	17

							
		  	2.24	  	No Other Business	  	17
				
		  	2.25	  	Other Representations and Warranties Relating to WFOE and OpCo	  	17
				
		  	2.26	  	Disclosure and Accuracy of Information	  	18
				
		  	2.27	  	Reliance	  	18
				
		  	2.28	  	Warranties Separate and Independent	  	18
				
		  	2.29	  	Business Plan	  	18
				
		  	2.30	  	Transactions with Affiliates	  	19
				
		  	2.31	  	Knowledge	  	19
			
	 3.
	  	Representations and Warranties of the Investor	  	19
				
		  	3.1  	  	Authorization	  	19
				
		  	3.2  	  	Purchase Entirely for Own Account	  	19
				
		  	3.3  	  	Investment Experience	  	20
				
		  	3.4  	  	No Public Market	  	20
				
		  	3.5  	  	Compliance with Laws	  	20
			
	 4.
	  	Conditions to Investors’ Obligations at Closing	  	20
				
		  	4.1  	  	Accuracy of Representations and Warranties	  	20
				
		  	4.2  	  	Performance	  	21
				
		  	4.3  	  	Compliance Certificate	  	21
				
		  	4.4  	  	Qualifications and Consents	  	21
				
		  	4.5  	  	Proceedings and Documents	  	21
				
		  	4.6  	  	Opinion of Company Counsel	  	21
				
		  	4.7  	  	Board of Directors	  	21
				
		  	4.8  	  	Registration Rights Agreement	  	21
				
		  	4.9  	  	Shareholders’ Agreement	  	21
				
		  	4.10	  	Officer’s Certificate	  	22
				
		  	4.11	  	No Material Adverse Change	  	22
				
		  	4.12	  	No Litigation	  	22
				
		  	4.13	  	Payment of Expenses	  	22
				
		  	4.14	  	Share Certificates	  	22
				
		  	4.15	  	Share Option Pool	  	22
				
		  	4.16	  	Minimum Commitment	  	22
				
		  	4.17	  	Confidentiality Agreement	  	22
				
		  	4.18	  	Compensation Committee	  	22

  

 ii 

							
		  	4.19	  	Authorized Shares	  	23
				
		  	4.20	  	OpCo Agreements	  	23
				
		  	4.21	  	Due Diligence	  	23
				
		  	4.22	  	Indemnification Agreement	  	23
				
		  	4.23	  	Executive Employment Agreements	  	23
				
		  	4.24	  	Financial Control Policies	  	23
				
		  	4.25	  	Loan	  	23
			
	 5.
	  	Conditions of the Company’s Obligations at Closing	  	24
				
		  	5.1  	  	Representations and Warranties True at Closing	  	24
				
		  	5.2  	  	Qualifications	  	24
				
		  	5.3  	  	Covenants	  	24
				
		  	5.4  	  	Registration Rights Agreement	  	24
				
		  	5.5  	  	Shareholders’ Agreement	  	24
			
	 6.
	  	Affirmative Covenants of the Group	  	24
				
		  	6.1  	  	Accounting and Reserves	  	24
				
		  	6.2  	  	Payment of Taxes and Claims	  	24
				
		  	6.3  	  	Availability of Ordinary Shares for Conversion	  	25
				
		  	6.4  	  	Governing Instruments	  	25
				
		  	6.5  	  	Use of Proceeds	  	25
				
		  	6.6  	  	Visa Contract	  	25
				
		  	6.7  	  	Bank Signatories	  	26
				
		  	6.8  	  	Registration of Media One Player	  	26
			
	 7.
	  	Miscellaneous Provisions	  	26
				
		  	7.1  	  	Inconsistent Agreements	  	26
				
		  	7.2  	  	Survival; Termination	  	26
				
		  	7.3  	  	Transfer of Successors and Assigns	  	26
				
		  	7.4  	  	Governing Law and Jurisdiction	  	26
				
		  	7.5  	  	Counterparts	  	27
				
		  	7.6  	  	Titles and Subtitles	  	27
				
		  	7.7  	  	Notices	  	27
				
		  	7.8  	  	Expenses	  	27
				
		  	7.9  	  	Attorneys’ Fees	  	28
				
		  	7.10	  	Amendments and Waivers	  	28

  

 iii 

							
				
		  	7.11	  	Severability	  	28
				
		  	7.12	  	Delays or Omissions	  	28
				
		  	7.13	  	Entire Agreement	  	28
				
		  	7.14	  	Further Assurances	  	28
				
		  	7.15	  	Specific Performance	  	29
				
		  	7.16	  	Understanding Among Investors	  	29
				
		  	7.17	  	Publicity	  	29
				
		  	7.18	  	Confidentiality and Non-Disclosure	  	29
				
		  	7.19	  	JAFCO Rights	  	31

  

 iv 

 SCHEDULES AND EXHIBITS 
  

			
	Designation	  	 Description

	Schedule I	  	Investors
		
	Schedule II	  	Schedule of Exceptions
		
	Schedule III	  	Particulars of the Company
		
	Schedule IV	  	Particulars of the Subsidiaries
		
	Schedule V	  	Leased Property
		
	Schedule VI	  	Notice Schedule
		
	Exhibit A	  	Form of Amended and Restated Memorandum and Articles of Association
		
	Exhibit B	  	Form of Registration Rights Agreement
		
	Exhibit C	  	Form of Shareholders’ Agreement
		
	Exhibit D-1	  	Shareholders and Persons Holding Options, Warrants, etc. Prior to Issuance of Series B Shares
		
	Exhibit D-2	  	Shareholders and Persons Holding Options, Warrants, etc. Assuming Issuance of Series B Shares
		
	Exhibit E	  	Form of Opinion of Company’s Cayman Islands Counsel
		
	Exhibit F	  	Form of Opinion of Company’s PRC Counsel
		
	Exhibit G	  	Form of Intellectual Property Rights Assignment, Non-Competition and Confidentiality Agreement
		
	Exhibit H	  	Business Plan
		
	Exhibit I	  	Form of Indemnification Agreement

  

 v 

 CGEN DIGITAL MEDIA COMPANY LIMITED 
 SERIES B REDEEMABLE CONVERTIBLE PREFERRED SHARES 
 PURCHASE AGREEMENT 

 THIS SERIES B REDEEMABLE CONVERTIBLE PREFERRED SHARES PURCHASE AGREEMENT (the
“Agreement”) is made and entered into as of the 16th day of January, 2006, by and among CGEN Digital Media Company Limited, an
exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), CGEN Media Technology Company Limited (“HK Co”), CGEN Digital Technology (Shanghai) Co., Ltd.
[GRAPHIC APPEARS HERE] (“WFOE”), a wholly foreign-owned enterprise organized under the laws of the People’s Republic of China (“PRC”), Shanghai CGEN Digital Media Network Co., Ltd.
[GRAPHIC APPEARS HERE], a domestic limited liability company registered in Shanghai, PRC (“OpCo”), Chan Yi Sing (Singapore NRIC No. S1306068A), Tian Guanyong (

) (PRC ID No. 133031651224065), Cao Xiaofeng (

) (PRC ID No. 310112197008270052), Yao Fang (

) (PRC ID No. 310221670521081) and Zhu Hai Guang (

) (PRC ID No. 410423197106070010) (together with Chan Yi Sing, Tian Guanyong (

) Cao Xiaofeng (

) and Yao Fang (

), the “Founders”, and each a “Founder”),(““,”; and together with the Company, HK Co, WFOE, OpCo and the Founders, the
“Warrantors” and each a “Warrantor”), and each of the other parties listed on Schedule I hereto identified as an investor (each of whom is referred to as an “Investor”). 

 WHEREAS, the Company desires to sell to the Investors at the Closing (as defined in Section 1.2 below), in accordance with the
terms hereof and for an aggregate cash consideration up to Ten Million Dollars (US$10,000,000) (excluding the Additional Closing, defined below), up to (i) Eighty-Eight Million One Hundred Eighty-One Thousand Nine Hundred Fifty-One
(88,181,951) of its authorized but unissued Series B Redeemable Convertible Preferred Shares, par value US$.000001 per share (the “Series B Shares”), which are convertible into the Company’s ordinary shares, par
value US$.000001 (the “Ordinary Shares” and, together with the Series B Shares, the “Securities”). 
 WHEREAS, subject to the terms and conditions of this Agreement, the Investors desire to purchase the Series B Shares from the Company in the amounts set forth on Schedule I hereto. 
 IT IS HEREBY AGREED AS FOLLOWS: 
 1. Terms of Purchase
and Sale. 
 1.1 Restated Articles. 
 The Company shall adopt on or before the date of the Closing an Amended and Restated Memorandum and Articles of Association in the form attached hereto as Exhibit A (the “Restated
Articles”). The rights, preferences and privileges of the Series B Shares will be as provided in the Restated Articles. 

 1.2 Purchase and Sale of Series B Shares. 
 Subject to the terms and conditions of this Agreement, each of the Investors agrees, severally and not jointly, to purchase from the Company at the
Closing, and the Company agrees to sell and issue to each of the Investors at the Closing, that number of Series B Shares as is set forth opposite such Investor’s name on Schedule I with the aggregate amount to be paid by each Investor
for the Series B Shares to be acquired by such Investor being as stated on Schedule I opposite such Investor’s name; provided, however, that the delivery by or on behalf of TDF Capital Advisors, LP and TDF Capital China II,
LP (collectively, “TDF”) to the Company or its counsel (which delivery, the Company acknowledges is made at its express request and direction) of U.S. dollar bank drafts in an aggregate amount of $1,870,367.88 made out to TOP
Result Promotion Ltd., Warburg, Pincus Ventures International, LP, HSBC International Trustee Limited account PAMA II shall constitute discharge by TDF of an amount of $1,870,367.88 out of the purchase price with respect to the Series B Shares to be
acquired by TDF hereunder and that the Company shall provide to TDF a receipt (in form and substance reasonably satisfactory to TDF) with respect to such amount of the purchase price upon delivery of such bank drafts. 
 1.3 The Closing. 
 (a) The closing of
the sale and purchase of the Series B Shares pursuant to this Agreement shall take place at the offices of O’Melveny & Myers LLP at 31st Floor, AIG Tower, One Connaught Road, Central, Hong Kong, on or about January 16, 2006, or at
such other time and place as the Company and each of the Investors may mutually agree (the “Closing”). 
 (b) At the
Closing, the Company shall deliver to each Investor a certificate representing that number of the Series B Shares set forth on Schedule I opposite the name of such Investor against payment of the purchase price therefor (in the amount set
forth opposite such Investor’s name on Schedule I) by bank check, wire transfer of immediately available funds, or such other form of payment as shall be mutually agreed upon by such Investor and the Company. If, at the Closing, any of
the conditions specified in Section 4 of this Agreement have not been fulfilled, each of the Investors shall, at its election, be relieved of all of its obligations under this Agreement. 
 1.4 Additional Closing(s). 
 (a)
Condition of Additional Closing(s). At any time and from time to time on or prior to 5 February 2006, the Company may, at one or more additional closings (each an “Additional Closing”), with the consent of the
Investors, offer and sell to other investors (“New Investors”), at a price per Series B Share equal to that paid by Investors at the Closing, up to that number of Series B Shares having an aggregate sale price not greater
than US$3.0 million. 
 (b) Amendments. The Company and the New Investors purchasing Series B Shares at each Additional Closing will
execute counterpart signature pages to this Agreement, the Registration Rights Agreement in the form attached as Exhibit B (the “Registration Rights Agreement”), the Shareholders’ Agreement in the form attached as
Exhibit C (the “Shareholders’ Agreement”) (together with the Restated Articles and the Registration Rights 

  

 2 

 
Agreement, the “Related Agreements”), and such New Investors will, upon delivery to the Company of such signature pages, become
parties to, and bound by, this Agreement, the Registration Rights Agreement and the Shareholders’ Agreement each to the same extent as if they had been Investors at the Closing. Immediately after each Additional Closing, Schedule I to
this Agreement will be amended to list the New Investors purchasing Series B Shares hereunder and the number of Series B Shares purchased by each New Investor under this Agreement at each such Additional Closing. The Company will promptly furnish to
each Investor copies of the amendments to Schedule I referred to in the preceding sentence. 
 (c) Status of New Investors.
Upon the completion of each Additional Closing as provided in this Section 1.3, each New Investor will be deemed to be an “Investor” for all purposes of this Agreement and an “Investor” for all purposes of the
Registration Rights Agreement and the Shareholders’ Agreement. 
 2. Representations and Warranties of the Warrantors. 
 Each Warrantor hereby represents and warrants jointly with the other Warrantors and severally to each Investor that, except as set forth on the Schedule
of Exceptions attached hereto as Schedule II (which exceptions shall be deemed to be representations and warranties as if made hereunder), each of the matters set out in this Section 2 is true and correct as at the date of this
Agreement and as at the Closing. 
 2.1 Organization Good Standing and Qualification. Schedule III sets out the full corporate
particulars of the Company. Schedule IV sets out full corporate particulars of each of the subsidiaries of the Company (the “Subsidiaries”) and Shanghai CGEN Digital Media Network Co., Ltd. The Company, the
Subsidiaries and OpCo shall be collectively referred to as the “Group” and each a “Group Company”, “member of the Group”, or “Group member”. The details
of each member of the Group as set out in Schedules III and IV are true and accurate. Each member of the Group is duly organized, validly existing and in good standing (or equivalent status in the relevant jurisdiction) under, and by
virtue of, the laws of the place of its incorporation or establishment and has the requisite corporate power, right and authority to carry on its business as now conducted and as proposed to be conducted. Each member of the Group is duly qualified
to transact business and is in good standing in each jurisdiction in which the failure so to qualify could reasonably be expected to have a material adverse effect on its, or the Group’s business, operations, operating results, properties,
assets, condition, liabilities or ability to perform any of its obligations under any contract or agreement (“Material Adverse Effect”). 
 2.2 Authorization. Each Warrantor has all requisite corporate power to execute and deliver this Agreement, to carry out and perform its obligations under this Agreement, to own, lease and operate its properties
and to carry on its business as now conducted, and as proposed to be conducted. All corporate action on the part of each Group Company, and its officers, directors and shareholders necessary for the authorization, execution and delivery of this
Agreement, the Restated Articles, the Registration Rights Agreement, the Shareholders’ Agreement, the performance of all obligations of each Warrantor hereunder and thereunder and the authorization, issuance and delivery of the Securities has
been taken or will be taken prior to the Closing, and this Agreement, the Restated Articles and the Related Agreements constitute valid and legally binding obligations of each Warrantor party hereto or thereto, enforceable 

  

 3 

 
against such Warrantor in accordance with their respective terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, and other laws of general application affecting the rights of creditors generally, as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, and
(ii) to the extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable securities laws. The Series B Shares, when issued in compliance with the provisions of this Agreement, will be duly
authorized, validly issued and will be fully paid and non-assessable and will have the rights, preferences and privileges described in the Restated Articles. The Ordinary Shares issuable upon conversion of the Series B Shares have been duly
authorized, duly and validly reserved and, when issued in compliance with the provisions of this Agreement and the Restated Articles will be duly authorized, validly issued, fully paid and non-assessable. The Securities will be free of any liens,
charges or encumbrances other than those created by or imposed upon the holders thereof through no action of any Warrantor, and the Securities will be free of restrictions on transfer, other than the restrictions on transfer under this Agreement and
the Related Agreements or under applicable securities laws. 
 2.3 Capitalization, Share Incentive Plan. 
 As at the date of this Agreement and immediately prior to Closing, the authorized and issued capital of the Company is as set out in Schedule III
and Exhibit D-1. The authorized capital of the Company consists, or will consist, contemporaneously with the Closing, of: 
 (a)
Preferred Shares. One Hundred Thirty Million (130,000,000) Series B Redeemable Convertible Preferred Shares, and One Hundred Million (100,000,000) Series A Redeemable Convertible Preferred Shares, par value US$.000001 per
share (the “Series A Shares”). The rights, privileges and preferences of the Series B Shares and the Series A Shares are as stated in the Restated Articles. Assuming purchase and subscription in full of all Series B Shares
available for purchase and subscription under this Agreement, the share capital of the Company (including without limitation issued shares, shares authorized for issuance and shares issuable upon exercise of authorized optional or convertible
securities) is set forth in the capitalization table in Exhibit D-2. 
 (b) Ordinary Shares. Seven Hundred Million
(700,000,000) Ordinary Shares, par value US$.000001 per share, of which One Hundred Million (100,000,000) are issued and outstanding, One Hundred Eleven Million (111,000,000) shall be reserved for issuance upon conversion of issued
and outstanding Series A Shares and One Hundred Fifty Million (150,000,000) shall be reserved for issuance upon conversion of issued and outstanding Series B Shares. 
 (c) Issued Shares. A true and complete list of (x) the Company’s shareholders and their holdings and (y) those Persons (as defined below) holding options, warrants or other rights to purchase any
class of the Company’s share capital (excluding conversion privileges of the Series B Shares and the Series A Shares) and their holdings, prior to the issuance of the Series B Shares purchased hereunder and assuming issuance of all
Series B Shares purchased hereunder, is set forth in Exhibits D-1 and D-2 respectively to this Agreement. All of the issued and outstanding shares of the Company as of the Closing are duly authorized, validly issued, 

  

 4 

 
fully paid and non-assessable and were issued in compliance with applicable securities laws. The Series B Shares have been duly authorized, and when issued,
sold, and delivered in accordance with the terms of this Agreement, will be duly and validly issued, fully-paid and non-assessable, will be issued in compliance with all applicable securities laws, and will be free of any preemption or similar
rights or liens, security interest, pledges, claims, restrictions, equities, charges and encumbrances of any nature whatsoever (“Encumbrances”) other than as contemplated by the Related Agreements. The Ordinary Shares
issuable upon the conversion of the Series B Preferred Shares in accordance with the Restated Charter, have been duly authorized, and upon issuance in connection with such conversion, will be duly and validly issued, fully-paid and non-assessable,
will be issued in compliance with all applicable securities laws, and will be free of any preemption or similar rights or Encumbrances other than as contemplated by the Related Agreements. Without prejudice to the foregoing provisions, Yi Sing CHAN
warrants and represents to the Investors that as at the date of this Agreement, he is the legal owner of 97,087,661 Ordinary Shares and 4,853,898 Series A Shares (the “Founder Shares”), that as at date hereof and as at
Closing the Founder Shares are duly and validly issued, fully-paid and non-assessable, have been issued in compliance with all securities laws, are free of any preemptive or similar rights and he has not provided any pledge, mortgage, lien,
encumbrance or security interest in respect of any such Founder Shares. 
 (d) Voting and Other Agreements. Except for conversion
privileges of the Series B Shares and the Series A Shares, there are no outstanding options, warrants, rights (including conversion or preemptive rights) or agreements, orally or in writing, for the purchase, redemption or acquisition from the
Company of any shares of its share capital. Except as otherwise contemplated herein, the Company is not a party or subject to any agreement or understanding, and, to the Knowledge of the Warrantors, there is no agreement or understanding between any
individual partnership, limited liability company, joint venture, corporation, association trust or any other entity or organization (collectively, a “Person”) that affects or relates to (A) the voting or giving of
written consents with respect to any security of the Company (including, without limitation, any voting agreements, voting trust agreements, shareholder agreements or similar agreements) or the voting by a director of the Company or (B) the
sale, transfer or other disposition with respect to any security of the Company. 
 2.4 Subsidiaries. The Company does not currently
own or control, directly or indirectly, any interest in any other corporation, association or other business entity other than in the Subsidiaries and OpCo. No Persons other than the Company or the WFOE holds any option, warrant or other right to
purchase any class of any share capital of any of the Subsidiaries or OpCo. All of the issued and outstanding shares of each of the Subsidiaries and OpCo are duly authorized, validly issued, fully paid and non-assessable and were issued in
compliance with applicable securities laws. 
 (a) Capitalization of CGEN HK 
 (i). The Company is the sole legal and beneficial shareholder of CGEN Media Technology Co., Ltd., a company organized under the laws of Hong Kong
(“CGEN HK”). 
 (ii). There are no outstanding rights of first refusal, preemptive 

  

 5 

 
rights or other rights, warrants, options, conversion privileges, subscriptions, or other agreements or securities, either directly or indirectly, entitling
the holder thereof to purchase or otherwise acquire or to compel CGEN HK to increase or decrease its authorized or issued share capital or to issue, repurchase or redeem any of such capital. 
 (b) Capitalization of WFOE. 
 (i).
Registered Capital. The registered capital of WFOE has been fully funded by CGEN HK in accordance with the terms of WFOE’s articles of association. CGEN HK is the sole legal and beneficial holder of all of the equity interest of WFOE.
Such capitalization of WFOE and the ownership of WFOE by CGEN HK have been approved by all relevant PRC authorities, which approvals are in full force and effect and have not lapsed or been revoked. 
 (ii). Other Securities. There are no outstanding rights of first refusal, preemptive rights, or other rights, warrants, options, conversion
privileges, subscriptions, or other rights, agreements or securities, either directly or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel the WFOE to increase or decrease the WFOE’s registered capital.

 (c) Capitalization of OpCo. 
 (i). All of the registered capital of OpCo has been paid in full. 
 (ii). GAO Weiming [GRAPHIC APPEARS HERE] holds 49.5
percent of record, CAO Xiaofeng (

) holds 18 percent of record, YAO Fang (

) holds 13.5 percent of record, TIAN Guanyong (

) holds ten percent of record and ZHU Haiguang (

) holds nine percent of record, respectively, of the equity interest in OpCo, as at the date hereof. 
 (iii). The Persons identified in paragraph (ii) are the only Persons with direct or indirect interests in the equity capital of OpCo, and each such Person holds its respective interests in OpCo free and clear of any Encumbrances,
except as provided under the call option agreement dated January [...], 2006 among WFOE, OpCo and the shareholders of OpCo (the “OpCo Call Option”). None of such Persons will transfer, alienate or dispose of any direct or
indirect interest in OpCo or create any Encumbrance over any such interest except as required pursuant to this Agreement or the OpCo Call Option. 
 (iv). Except pursuant to the OpCo Call Option, there are no outstanding rights of first refusal, preemptive rights or other rights, warrants, options, conversion privileges, subscriptions, or other agreements or securities, either directly
or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel OpCo to increase or decrease its registered capital or to issue, repurchase or redeem any of such registered capital or its issued capital. 
 2.5 Compliance with Other Instruments. No member of the Group is in violation or default of any provisions of (i) its Articles and Memorandum
of Association (or equivalent charter documents) or (ii) any instrument, contract, undertaking, understanding, indenture or 

  

 6 

 
agreement to which it is a party or by which it is bound (each a “Contract”) or of any judgment, order, writ, decree, statute, rule
or regulation applicable to such member of the Group, except where any such violation or default could not reasonably be expected to result in (x) the Group member’s loss of any right granted under any Contract or (y) a Material
Adverse Effect. The execution, delivery and performance of this Agreement, the Related Agreements and the consummation of the transactions contemplated hereby and thereby will not result in any violation, or constitute a default, by any member of
the Group under any such Contract, judgment, order, writ, decree, statute, rule or regulation or an event that results in the creation of any lien, charge or encumbrance upon any assets of any member of the Group whether with or without the passage
of time or the giving of notice, or both. 
 2.6 Consents. No consent, approval, license, order or authorization of, or registration,
qualification, designation, declaration or filing with, any governmental authority or any party to a Contract or any other third party is required by any Warrantor in connection with (x) the valid execution and delivery of this Agreement and
the Related Agreements, (y) the offer and sale of the Securities or (z) the consummation of the transactions contemplated by this Agreement and the Related Agreements, except such filings as may be required under applicable securities
laws, which filings will be timely filed within the applicable periods therefore. 
 2.7 Permits. Each member of the Group has all
franchises, permits, licenses and any similar authority as necessary for the conduct of its business as now being conducted by it, except for those franchises, permits, licenses or similar authority the failure of which to obtain could not
reasonably be expected to have a Material Adverse Effect. No member of the Group is in material default under any of such franchises, permits, licenses or other similar authority. The execution, delivery and performance of and compliance with this
Agreement and Related Agreements and the issuance of the Securities will not result in suspension, revocation, impairment, forfeiture or non-renewal of any such franchise, permit, license or similar authority that could reasonably be expected to
result in a Material Adverse Effect. 
 2.8 Litigation. There is no action, suit, proceeding or investigation pending or, to the
Knowledge of each Warrantor, currently threatened against any member of the Group or any of their respective properties nor to the Knowledge of any Warrantor is there any basis for the foregoing, including, without limitation, any action, suit,
proceeding or investigation that questions the validity of this Agreement or any Related Agreement or any action to be taken in connection herewith or therewith. No member of the Group nor any of their respective properties is a party or subject to
the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality. There is no action, suit, proceeding or investigation by any member of the Group currently pending or which any member of the
Group currently intends to initiate. 
 2.9 Patents and Other Intangible Assets. 
 (a) All patents and patent rights, entity models, trademarks and trademark rights, trade names and trade name rights, service marks and service mark
rights, service names and service name rights, brand names, internet domain names and sub-domains, inventions, processes, formulas, copyrights and copyright rights, trade dress, business and product names, logos, slogans, trade secrets, industrial
models, processes, designs, methodologies, computer 

  

 7 

 
programs (including all source codes), license rights to use packaged software and related documentation, technical information, manufacturing, engineering
and technical drawings, know-how and all pending applications for and registrations of patents, entity models, trademarks, service marks, copyrights and internet domain names and sub-domains (collectively, “Intellectual
Property”) used in the business or businesses of any member of the Group: 
 (i) is owned by the Company or relevant member of
the Group as the sole legal and beneficial owner, free of any license or encumbrance in favor of a third party (the “Group’s Intellectual Property”); or 
 (ii) is used by the Group in accordance with the terms of a current license from the owner of that Intellectual Property (“Licensed
IP”). 
 (b) Each of the Group’s Intellectual Property that is material to the business or businesses of any member of the
Group is set forth in Schedule 2.9(c). 
 (c) None of the Group’s Intellectual Property has been wrongfully or unlawfully
acquired by the Group. Each of the registrations (and applications therefor) of the Group’s Intellectual Property is valid. Neither any member of the Group nor any other Person has breached or alleged a breach of any of the licenses under the
Licensed IP during the six years preceding the date of this Agreement. The Group’s Intellectual Property, and the validity or subsistence of the Group’s right, title and interest therein, is not the subject of any current, pending or
threatened challenge, claim or proceedings, including for opposition, cancellation, revocation or rectification, and has not during the period of six years prior to Closing been the subject of any challenge, claim or proceeding, and to the
Company’s Knowledge there are no facts or matters that might give rise to any such challenge, claim or proceeding. The Group has taken commercially reasonable efforts to preserve the Group’s Intellectual Property and without limitation,
all renewal fees regarding the Group’s Intellectual Property due on or before Closing have been paid in full. No member of the Group has entered into any agreement, arrangement or understanding (whether legally enforceable or not) for the
licensing, or otherwise permitting the use or exploitation, of the Group’s Intellectual Property or that prevents, restricts or otherwise inhibits the Group’s freedom to use and exploit the Group’s Intellectual Property. To the
Knowledge of each Warrantor, none of the Group’s Intellectual Property is currently being infringed by any third party or has been so infringed during the six-year period preceding Closing and no third party has threatened any such
infringement. No third party has, during the two years preceding the date of this Agreement made, threatened or brought any challenge, claim or proceedings in relation to the Group’s use of the Licensed IP (and to each Warrantor’s
Knowledge there are no facts or matters that might give rise to any such challenge, claim or proceedings). The carrying on of the Group’s business or businesses as presently constituted does not require any licenses or consents from (except for
standard end-user agreements with respect to commercially readily available intellectual property such as “off the shelf” computer software and for Licensed IP), or the making of royalty or similar payments to, any third party, to the
Knowledge of the Warrantors no member of the Group uses or needs to use any processes or is engaged in any activities that infringe any Intellectual Property belonging to any third party and no member of the Group has within the six years preceding
this Agreement used any Intellectual Property in a way that has infringed or infringes the Intellectual Property rights of a third party. No Warrantor has any Knowledge that that any employees of any Group member is 

  

 8 

 
obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of
any court, that would interfere with the use of such employees’ best efforts to promote the interest of the Group or that would conflict with the Group’s business as conducted. Neither the execution nor delivery of this Agreement, nor the
carrying on of the Group’s business by the employees of the Group as conducted will, to the Knowledge of each Warrantor, conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any
contract, covenant or instrument under which any such employee is now obligated. To the Knowledge of each Warrantor, it is not and will not be necessary to use any inventions of any of employees of any Group member (or persons it currently intends
to hire) made prior to their employment with the Group. Each Founder and each officer or employee of any Group Company who has developed any Intellectual Property in the course of his or her employment or service with the Group has, where necessary,
validly assigned to the Company or the WFOE all rights, title and interest that he or she may have in or to any such Intellectual Property. 
 (d) No member of the Group has entered into any agreement, other than as set forth on Schedule 2.9(d) and provided to the Investors or their counsel, to indemnify any other person against any charge of infringement or
misappropriation of any Group’s Intellectual Property. 
 (e) Each Group Company has taken all reasonably necessary action to protect
and preserve (i) the validity and enforceability of trade and service marks and associated goodwill included in the Group’s Intellectual Property; (ii) the enforceability of copyrights and the confidentiality, validity and
enforceability of pending patent applications included in the Group’s Intellectual Property; (iii) the validity and enforceability of patents included in the Group’s Intellectual Property; and (iv) the confidentiality and
enforceability of trade secrets and the confidentiality of other proprietary information included in the Group’s Intellectual Property. 
 (f) There is no agreement pursuant to which any current or former employee or consultant of any Group Company has rights to any part of the Group’s Intellectual Property. 
 (g) Each Founder, and each senior manager and key technical employee of the Group identified in Schedule 2.9(g), has or as of Closing will have
executed an Intellectual Property Rights Assignment, Non-Competition and Confidentiality Agreement substantially in the form of Exhibit G to this Agreement (a “Confidentiality Agreement”). 
 2.10 Marketing Rights. No member of the Group has granted rights to market or sell its products to any other Person and no member of the Group is
bound by any agreement that affects any such member of the Group’s exclusive right to market or sell its products. 
  

 9 

 2.11 Agreements, Action. 
 Save as disclosed in Schedule 2.11, neither the Company nor any member of the Group is a party to or bound by: 
 (a) any note, bond debenture or other evidence of indebtedness, or any Contract, judgment, order, writ, decree, commitment or
understanding under which it has borrowed any money or issued any note, bond, debenture or other evidence of indebtedness, or any mortgage, pledge, security agreement, deed of trust, financing statement or other document granting any lien,
encumbrance or security interest (including liens, encumbrances or security interests upon properties acquired under conditional sales, capital leases and other title retention or security devices), or any guaranty or endorsement (other than
endorsements for collection in the ordinary course of business) of, or other contingent obligations in respect of, indebtedness for borrowed money or other liabilities or obligations of others, in any separate case in excess of US$50,000 in
principal amount or US$100,000 in the aggregate; 
 (b) any Contract, judgment, order, writ, decree, commitment, arrangement
or understanding relating to any joint venture, partnership or sharing of profits or losses with any Person or entity or permitting any Person or entity to use any technology, know-how or proprietary information of the Company; 
 (c) any Contract, instrument, judgment, order, writ, decree, commitment for the future purchase by any member of the Group of any
materials, equipment, services or supplies that (A) involves the payment of more than US$50,000, (B) continues for a period of more than twelve months, (C) by its terms requires the Company to purchase the entire output or services of
a supplier or (D) provides that any supplier will be the exclusive supplier of the Group; 
 (d) any Contract,
instrument, judgment, order, writ or decree for the sale or other disposition by the Group of its assets or properties other than in the ordinary course of business, or for the merger, or consolidation of any member of the Company with any other
Person; 
 (e) any Contract, instrument, judgment, order, writ or decree containing covenants purporting to limit the freedom
of the Group to compete in any line of business or in any geographic area; 
 (f) any Contract, instrument, judgment, order,
writ or decree not elsewhere specifically disclosed pursuant to this Agreement involving the payment or receipt by any member of the Group of more than US$50,000 per year or US$100,000 over the term thereof; 
 (g) any Contract with a consultant which provides for payment during the term of the Contract of more than US$50,000; 
 (h) any Contract with any employee of the Group that provides for payment of US$50,000 or more per annum; or 
 (i) any sale or purchase option or similar contract or arrangement affecting any assets owned or used by any Group Company or by which any
Group Company is bound; or 
  

 10 

 (j) any agreements restricting the freedom of any member of the Group to provide and take
goods and services or to manage its own business affairs by such means and from and to such persons as it may from time to time think fit. 
 Other than as required by this Agreement, the Related Agreements, the Restated Charter and the Contracts identified in Section 2.11 of Schedule II, (i) no Group Company has entered into any agreement with, or given
any undertaking or assurance to, any of the existing shareholders of the Company or their affiliates, and (ii) there are no agreements binding on the Company which prohibit or restrict the sale, disposal or transfer of any equity securities (or
any interests therein) owned by the Company. 
 True and complete copies of all Contracts identified in Section 2.11 of
Schedule II (collectively, the “Scheduled Contracts”) have been provided to counsel for the Investors. The Company has not received any notification of any breach, or default under any of the Scheduled Contracts.

 No member of the Group has (i) declared or paid any dividends, or authorized or made any distribution upon or with respect to any
class or series of its share capital, (ii) other than as expressly set forth in the Financial Statements (as defined below in Section 2.17), incurred any indebtedness for money borrowed or incurred any other liabilities individually
in excess of US$500,000 or in excess of US$1,000,000 in the aggregate, (iii) made any loans or advances to any Person or entity other than ordinary advances for travel expenses for employees in the ordinary course of business, or
(iv) sold, exchanged or otherwise disposed of any of its assets or rights other than in the ordinary course of business and at arm’s length. 
 No member of the Group is a party to or bound by any Contract, or subject to any restriction under its Charter or other constitutional documents that will have a Material Adverse Effect. 
 2.12 Brokers or Finders. Except as shown on the Schedule of Exceptions, no member of the Group has incurred, and will not incur, directly or
indirectly, as a result of any action taken by the Company, any liability for brokerage or finders’ fees or agents’ commissions or any similar charges in connection with this Agreement and the Related Agreements. 
 2.13 No Conflict of Interest. Except as described in the Financial Statements, no member of the Group is indebted, directly or indirectly, to any
of its officers, directors or shareholders in any amount whatsoever other than in connection with expenses or advances of expenses incurred in the ordinary course of business. None of the officers, directors or shareholders of any member of the
Group is indebted to such member of the Group, or any other member of the Group or, to each Warrantor’s Knowledge, have any direct or indirect ownership interest in any firm or corporation with which any member of the Group is affiliated or
with which any member of the Group has a business relationship, or any firm or corporation that competes with the Group. No member of the Group is a guarantor or indemnitor of any indebtedness of any other Person. None of the officers, directors or
shareholders of any member of the Group is directly or indirectly interested in any Contract with a member of the Group. None of the officers, directors or shareholders of any member of the Group or any affiliate of any 

  

 11 

 
such Person has had, either directly or indirectly, any interest in (a) any Person that purchases from or sells, licenses or furnishes to a member of
the Group any goods, property, proprietary assets, Intellectual Property or other property rights or services; or (b) any Contract or agreement to which a member of the Group is a party or by which it may be bound or affected. 
 2.14 Rights of Registration. Except as contemplated in the Registration Rights Agreement, at the time of Closing no member of the Group will be
obligated to grant to any Person any registration rights, including piggyback rights, that are pari passu or senior to the registration rights to be granted pursuant to the Registration Rights Agreement. 
 2.15 Corporate Documents and Minute Books. The copy of the minute books of the Company provided to the counsel for the Investors contains minutes
of all meetings of directors (including committees thereof) and shareholders and all actions by written consent without a meeting by the directors and shareholders since the date of incorporation and reflects all actions by the directors (and any
committee of directors) and shareholders with respect to all transactions referred to in such minutes accurately in all material respects. Each Group Company has properly kept all books, records and registers required to be kept by it under any
applicable material laws. Each Group Company has filed or delivered all material returns, particulars, resolutions and other documents required to be filed with or delivered to any governmental authority in respect of such Group Company. 

2.16 Title to Property and Assets. (a) Each member of the Group owns its property and assets free and clear of all mortgages, liens, loans
and encumbrances, except such mortgages, encumbrances, loans and liens that arise in the ordinary course of business and do not materially impair such member of the Group’s ownership or use of such property or any assets. With respect to the
property and assets it leases, including the leased property described on Schedule V, the relevant member of the Group is in compliance in all material respects with such leases and, to each Warrantor’s Knowledge, holds a valid leasehold
interest free of any material liens, claims, loans or encumbrances and is in compliance with such leases. 
 (b) Each member of the Group
owns or has a valid right to use all its property and assets necessary for its business as now conducted, including the leased property described on Schedule V, and, to Knowledge of each Warrantor, without any infringement of the rights of
others. There are no outstanding options, licenses or agreements of any kind granted by any member of the Group relating to any of its property or assets, nor is any member of the Group bound by or a party to any options, licenses or agreements of
any kind with respect to any of the property or assets of any other Person except, in either case, for standard end-user agreements with respect to commercially readily available intellectual property such as “off the shelf” computer
software and the Licensed IP. 
 (c) Except as would not have a Material Adverse Effect, the assets owned, possessed or used by the Group
comprise all the assets required to enable the Group to carry on its business in the ordinary course. 
 (c) No debt owed to any Group member
is more than three months overdue for payment. No Group member has released any debt on terms permitting the debtor thereunder to pay less than the book value of the debt, and no debt owing to any Group member has been deferred, subordinated or
written off or is reasonably believed to be unrecoverable. 
  

 12 

 2.17 Financial Statements. (a) The Company has delivered to the Investors its unaudited
consolidated financial statements (including balance sheet and profit and loss statement and statement of cash flows, the “Financial Statements”) as of and for the nine months ended September 30, 2005 (the
“Balance Sheet Date”). The Financial Statements truly and fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein. Except as
set forth in the Financial Statements, neither the Company nor any Subsidiary has any liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business and at arm’s length subsequent to the
Balance Sheet Date and (ii) obligations under contracts and commitments incurred in the ordinary course of business and at arm’s length, which, in both cases, individually or in the aggregate would not have a Material Adverse Effect.

 (b) The Company has delivered to the Investors the audited financial statements (including balance sheet and profit and loss statement and
statement of cash flows) of OpCo as of and for the nine months ended September 30, 2004, and its unaudited consolidated financial statements (including balance sheet and profit and loss statement and statement of cash flows, as of and for the
year ended September 30, 2005 (the “OpCo Financial Statements”) which truly and fairly present in all material respects the financial condition and operating results of OpCo as of the dates, and for the periods,
indicated therein. Except as set forth in such financial statements, OpCo has no liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business and at arm’s length subsequent to
September 30, 2005 and (ii) obligations under contracts and commitments incurred in the ordinary course of business and at arm’s length, which, in both cases, individually or in the aggregate would not have a Material Adverse Effect.

 (c) Full disclosure of and adequate provisions for bad and doubtful debts and all liabilities, actual, contingent or otherwise and of all
financial commitments in existence at the Balance Sheet Date have been made in the Financial Statements and the OpCo Financial Statements. 
 (d) The results shown by the Financial Statements and the OpCo Financial Statements on the Balance Sheet Date have not (save as therein disclosed) been affected by an extraordinary or exceptional or non-recurring item or by any other
circumstances rendering the profits or losses for the period covered by the Financial Statements and the OpCo Financial Statements unusually high or low. 
 (e) The Financial Statements and the OpCo Financial Statements reserve or provide in full for all Taxation (as defined below) for which the Group was at the Balance Sheet Date liable, and whether or not the Group has
or may have any right of reimbursement against any other Person, the Financial Statements and the OpCo Financial Statements have provided for in full for any contingent or deferred liability to Taxation. 
 (f) None of the Group’s assets has been acquired for any consideration in excess of its net realizable value at the date of such acquisition or
otherwise than by way of a bargain at arm’s length. 
  

 13 

 (g) The rates of depreciation adopted in the Financial Statements and the OpCo Financial Statements were
sufficient for each fixed asset of the Group to be written down to nil by the end of its useful life. 
 (h) The management accounts have
been prepared in accordance with the disclosed accounting policies of the Group and on a consistent basis as those used in the audited accounts and show a fair view of the assets and liabilities, profits and losses of the Group as at and to the date
of the management accounts. 
 (i) The Financial Statements and the OpCo Financial Statements have been prepared in accordance with the
requirements of the relevant statutes and on a consistent basis. 
 2.18 Changes. For the purposes of this Section 2.18,
the Financial Statements shall be deemed to include the OpCo Financial Statements. Since September 30, 2004, there has not been: 
 (a) any change in the business, assets, properties, liabilities, condition or operating results of the Group from that reflected in the Financial Statements, except changes in the ordinary course of business that
could not result in a Material Adverse Effect; 
 (b) any damage, destruction or loss, whether or not covered by insurance,
materially and adversely affecting the business, assets, properties, liabilities or condition or operating results of the Group; 
 (c) any waiver (or partial waiver) or compromise by any member of the Group of a valuable right or of a material debt owed to it; 
 (d) any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by any member of the Group, except in the ordinary course of business that is not material to the business, properties
or condition of such member of the Group; 
 (e) any material change to a Contract entered into by any member of the Group;

 (f) any change in any compensation arrangement or agreement with any employee, officer, director, shareholder, consultant
or finder of any member of the Group; 
 (g) any sale, disposition, assignment or transfer of Group’s Intellectual
Property; 
 (h) any sale, disposition, assignment or transfer of any tangible assets of the Group, except in the ordinary
course of business; 
 (i) any resignation or termination of employment of any officer or key employee of the Group and there
is no impending resignation or termination of employment of any director, officer or employee of any Group member that, if consummated, is likely to have a Material Adverse Effect; 
  

 14 

 (j) receipt of notice that there has been a loss of, or order cancellation by, any major
customer of any member of the Group or cancellation or discontinuance by any major supplier or service provider of any member of the Group; 
 (k) any mortgage, pledge, transfer of a security interest in, or lien, created by any member of the Group with respect to any of its properties or assets, except liens for taxes not yet due or payable; 
 (l) any payment, loan, advance or guaranty made by any member of the Group to, or any sale, transfer or lease of any properties or assets
by any member of the Group or any other agreement or arrangement entered into by any member of the Group with or for the benefit of, its employees, officers, directors or shareholders other than travel advances to employees or directors made in the
ordinary course of its business consistent with past practice; 
 (m) any declaration, setting aside or payment or other
distribution in respect to any of the share capital of any member of the Group, or any direct or indirect redemption, purchase or other acquisition of any of such share capital by any member of the Group; 
 (n) any change in the line of business of any member of the Group; 
 (o) any debt, obligation (other than contracts with the Group’s customers in the ordinary course of business), or liability incurred,
assumed or guaranteed by any member of the Group individually in excess of US$500,000; or 
 (p) any arrangement or commitment
by any member of the Group to do any of the above items described in this Section 2.18. 
 2.19 Employment Benefit Plans.
No member of the Group is a party to or bound by any currently effective employment contract, deferred compensation arrangement, bonus plan, incentive plan, profit sharing plan, retirement agreement or other employee or consultant compensation plan
or agreement. No employee of any member of the Group has been granted the right to continued employment by such member of the Group or to any material compensation following termination of employment with such member of the Group. 
 2.20 Tax, Tax Returns and Payments. (a) Each member of the Group has filed or caused to be filed all required Tax Returns (as defined below)
with the appropriate governmental agencies in all jurisdictions in which such Tax Returns are required to be filed by each member of the Group and all Taxes (as defined below) shown on such Tax Returns payable by such entity have been properly
accrued or paid to the extent such Taxes have become due or are being contested in good faith, and for which reserves therefor have been established by the Group in accordance with generally accepted accounting principles. No member of the Group has
executed any waiver or extensions of any statute of limitations on the assessment or collection of any Tax or with respect to any liability arising therefrom. None of the income Tax Returns for any member of the Group has been audited by any taxing
authority. To the Knowledge of each 

  

 15 

 
Warrantor, no member of the Group is or expects to be involved in any dispute in relation to Tax and there is no relevant governmental authority concerned
which has investigated or indicated that it intends to investigate the Tax affairs of any member of the Group. For purposes of Section 2.17 and this Section 2.20, “Taxes” means and includes all forms of tax,
levy, duty, charge, impost, fee, deduction or withholding of any nature imposed, levied, collected withheld or assessed by any governmental authority or other taxing or similar authority in any part of the world and includes (i) any interest,
additional tax, penalty or other charge payable or claimed in respect thereof and (ii) any central, provincial or local taxes, assessments, interest, penalties, deficiencies, fees and other governmental charges or impositions; and
“Tax Return” means any central, provincial or local tax return, report, statement and other similar filings required to be filed by any member of the Group with respect to Taxes. 
 (b) The provisions for taxes in the respective Financial Statements are sufficient for the payment of all accrued and unpaid applicable taxes of the
relevant member of the Group, whether or not assessed or disputed as of the date of each such balance sheet. There have been no examinations or audits of any tax returns or reports by any applicable governmental authority, except during routine
annual inspection of the OpCo and the Subsidiaries incorporated in the PRC by the relevant PRC governmental authorities nor has any such governmental authority notified any Group member of its intention to do so. Since the Balance Sheet Date, none
of the members of the Group has incurred any taxes, assessments or governmental charges other than in the ordinary course of business and each member of the Group has made adequate provisions on its books of account for all taxes, assessments and
governmental charges with respect to its business, properties and operations for such period. No member of the Group has entered into or been engaged in or been a party to any transaction or series of transactions or scheme or arrangement of which
the main or dominant purpose or one of the main or dominant purposes was the avoidance or deferral of or reduction in the liability to tax of such member of the Group. No tax scheme in effect, as previously applied in the Financial Statements has
been illegal under any applicable laws. 
 2.21 Insurance. Each member of the Group has in full force and effect insurance policies in
amounts customary for companies similarly situated and nothing has been done or omitted to be done by or on behalf of such member of the Group that would make any policy of insurance void or voidable or enable the insurers to avoid the same and
there is no claim outstanding under any such policy and to the Knowledge of each Warrantor there are no circumstances likely to give rise to such a claim or result in an increased rate of premium. All information furnished in obtaining or renewing
the insurance policies of any member of the Group was accurate in all material respects when given and any change in that information required to be given was correctly given in all material respects. No member of the Group is in default under any
of these policies or suffered any uninsured losses or waived any rights of material or substantial value or allowed any insurances to lapse. No Group member has been refused any insurance coverage sought or applied for, and the Company has not been
notified in writing that it will be unable to renew its existing insurance coverage. 
 2.22 Labor Agreements and Actions. No member
of the Group is bound by or subject to any written or oral, express or implied, contract, commitment or arrangement (including, without limitation, collective bargaining agreements) with any labor union, and no labor union has requested or, to the
Knowledge of each Warrantor, has sought to represent any of the 

  

 16 

 
employees, representatives or agents of any member of the Group. There is no strike or other labor dispute involving any member of the Group pending, or to
the Knowledge of each Warrantor, threatened, that could reasonably be expected to have a Material Adverse Effect. Each member of the Group has complied in all material respects with all applicable laws related to employment. No member of the Group
has engaged in any unfair labor practice that could reasonably be expected to result in a Material Adverse Effect. No member of the Group has a present intention to terminate the employment of any officer or key employee, or any group of key
employees. 
 2.23 Environmental and Safety Laws. To each Warrantor’s Knowledge, no member of the Group is in violation in any
material respect with any applicable statute, law or regulation relating to the environment or occupational health and safety that would have a material adverse effect on its employees, and to the Knowledge of each Warrantor, no material
expenditures are or will be required in order to comply with any such existing statute, law or regulation. 
 2.24 No Other Business.
The Company was formed solely to acquire and hold an equity interest in CGEN HK and WFOE (indirectly through its ownership of CGEN HK). Since their formation, the Company and the CGEN HK have not engaged in any business and have not incurred any
liability except in the ordinary course of their business of acquiring and holding the equity interest of CGEN HK and WFOE, respectively. 
 2.25 Other Representations and Warranties Relating to WFOE and OpCo. 
 (a). The constitutional documents and
certificates and related material Contracts of WFOE and OpCo are valid and have been duly approved or registered (as applicable) by competent PRC governmental authorities. 
 (b). All material consents, approvals, authorizations or licenses requisite under the PRC law for the due and proper establishment and
operation of WFOE and OpCo have been duly obtained from the relevant PRC governmental authorities and are in full force and effect. 
 (c). All filings and registrations with the PRC governmental authorities required in respect of WFOE and OpCo and its operations including, without limitation, the registrations with Ministry of Commerce, State Administration of Industry
and Commerce, State Administration for Foreign Exchange, tax bureau and customs authorities have been duly completed in accordance with the relevant PRC rules and regulations. 
 (d). each of WFOE and OpCo has complied with all relevant PRC laws and regulations regarding the contribution and payment of its
registered share capital, the payment schedule of which has been approved by the relevant PRC government authorities. There are no outstanding rights of, or commitments made by any member of the Group to sell any equity interest in WFOE or OpCo, as
applicable. 
  

 17 

 (e). each of WFOE and OpCo is not in receipt of any letter or notice from any relevant
PRC governmental authority notifying it of revocation of any licenses issued to it for non-compliance or the need for compliance or remedial actions in respect of the activities carried out by WFOE or OpCo as the case may be. 
 (f). each of WFOE and OpCo has conducted its business activities within the permitted scope of business or has otherwise operated its
business in material compliance with all relevant legal requirements and with all requisite licenses and approvals granted by competent PRC governmental authorities. 
 (g). As to licenses and approvals requisite for the conduct of any part of WFOE’s or OpCo’s, as applicable, business which are
subject to periodic renewal, no Warrantor has any Knowledge of any grounds on which such requisite renewals will not be granted by the relevant PRC governmental authorities. 
 (h). With regard to employment and staff or labor, each of OpCo and WFOE has complied with all applicable PRC laws and regulations in all
material respects, including without limitation, laws and regulations pertaining to welfare funds, social benefits, medical benefits, insurance, retirement benefits, pensions or the like. 
 2.26 Disclosure and Accuracy of Information. Each Warrantor has fully provided the Investors with all the relevant information that the Investors
(or their counsel) have requested for deciding whether to subscribe for the Series B Shares and, to the Knowledge of the Warrantors, all information necessary to enable each Investor to make a fully informed decision as to whether or not to
subscribe for the Series B Shares. All information contained in this Agreement (including the Recitals, Exhibits and the Schedules) and the other documents referred to herein (except such information as provided by the Investors) and the Related
Agreements is true, accurate and complete in all respects and not misleading in any respect. 
 2.27 Reliance. The Warrantors
acknowledge that the Investors have entered into this Agreement in reliance upon the representations and warranties given by them and that they are given with the intention of inducing the Investors to enter into this Agreement. 
 2.28 Warranties Separate and Independent. Each of the warranties is separate and independent and, except as provided in the Schedule of
Exceptions, is not limited: (a) by reference to any other paragraph of Section 2; or (b) by anything in this Agreement, and none of the warranties shall be treated as qualified by any constructive knowledge on the part of the
Investors or any of their respective agents. Each of the warranties is without prejudice to any other warranty and, except where expressly stated otherwise, no provision contained in this Agreement shall govern or limit the extent or application of
any other warranty. A reference made to a particular part of a document when making a disclosure under the Schedule of Exceptions of any matter shall not be treated as a disclosure of the whole document. 
 2.29 Business Plan. The business plan of the Group set forth in Exhibit H (the “Business Plan”), including the
budget, capital expenditure plan and projections set forth 

  

 18 

 
therein, has been drawn up based on fair, proper and reasonable assumptions in good faith and in a professional workmanlike manner and on a realistic basis,
after due and careful consideration of all relevant facts and circumstances, and does not give a misleading indication of the prospects of the Group. There has been no omission from the Business Plan that would make it misleading. 
 2.30 Transactions with Affiliates. Except as required by this Agreement, the Related Agreements, the Restated Charter, the contractual arrangement
between WFOE and OpCo or the transactions contemplated hereby or thereby, (i) no director or senior manager of any member of the Group, no spouse, parent, sibling or children of any such director or senior manager, and no entity controlled by
any of the foregoing, has any agreement, understanding, proposed transaction with, indebtedness owing to, commitments to make loans or to extend or guarantee credit from any member of the Group other than in the ordinary course of business;
(ii) the sum of the value of all agreements, understandings, proposed transactions with, indebtedness owing to, commitments to make loans or to extend or guarantee credit by all members of the Group with respect to any director or senior
manager of the Group, the spouse, parents, siblings and children of such director or senior manager, and any entity in which such director, senior manager or such relatives thereof have a direct or indirect ownership interest of not less than 0.1%,
do not exceed US$10,000; and (iii) no director or senior manager of any member of the Group, no spouse, parent, sibling or children of any such director or senior manager, and no entity controlled by any of the foregoing, has any direct or
indirect ownership interest in any affiliate of any member of the Group or in any firm or corporation that competes with any member of the Group. 
 2.31 Knowledge. In this Agreement, “Knowledge” means best knowledge, of the entity to which knowledge is attributed and includes knowledge, information, belief or awareness that it would have if its principal
executive and financial officers had made due and diligent enquiries and investigation. 
 3. Representations and Warranties of the Investor. 

 Each Investor, severally and not jointly, hereby represents and warrants to the Company as follows: 
 3.1 Authorization. This Agreement and the Related Agreements, when executed and delivered by such Investor, will each constitute a valid and
legally binding obligation of such Investor, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application
affecting enforcement of creditors rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (ii) to the extent the indemnification provisions contained in
the Registration Rights Agreement may be limited by applicable securities laws. 
 3.2 Purchase Entirely for Own Account. This
Agreement is made with the Investor in reliance upon the Investor’s representation to the Company, which by the Investor’s execution of this Agreement the Investor hereby confirms, that the Series B Shares to be acquired by the Investor
will be acquired for investment for the Investor’s own account, not as a nominee or 

  

 19 

 
agent, and not with a view to the resale or distribution of any part thereof in violation of securities laws. The Investor represents that it has the
requisite power and authority to enter into, execute, deliver and perform this Agreement. 
 3.3 Investment Experience. Each Investor
represents that such Investor is experienced in evaluating and investing in private placement transactions of securities of companies in a similar stage of development to the Company and acknowledges that such Investor is able to fend for himself,
herself or itself, can bear the economic risk of such Investor’s investment, and has such knowledge and experience in financial and business matters that such Investor is capable of evaluating the merits and risks of the investment in the
Securities. Without prejudice to the representations and warranties of the Company herein or its obligations hereunder, the Investor has had the opportunity to inquire of the Company and its senior management regarding information the Investor
believes is necessary for it to make an informed decision in purchasing the Securities, has received all information so requested and has had the opportunity to conduct such due diligence review as it has deemed appropriate. 
 3.4 No Public Market. The Investor acknowledges that the Securities must be held indefinitely. The Investor understands that no public market now
exists for any of the securities issued by the Company, that the Company has made no assurances that a public market will ever exist for the Securities. 
 3.5 Compliance with Laws. Such Investor is satisfied as to the full observance of the securities laws of such Investor’s jurisdiction in connection with any invitation to subscribe for the Series B Shares
or any transaction contemplated by this Agreement, including (i) the legal requirements of such Investor’s jurisdiction for the purchase of the Series B Shares and (ii) any governmental or other consents that may be relevant to the
purchase, holding, redemption, sale or transfer of the Securities. Such Investor’s subscription and payment for, the Securities will not violate any applicable securities laws of such Investor’s jurisdiction. 
 4. Conditions to Investors’ Obligations at Closing. 
 The obligations of each of the Investors under this Agreement are subject to the fulfillment, or the waiver by each of the Investors, of the conditions set forth in this Section 4 on or before the Closing.

 4.1 Accuracy of Representations and Warranties. Each representation and warranty of the Warrantors contained in this Agreement
shall be true in all material respects (except that the representations and warranties contained in Sections 2.1, 2.2 and 2.3 shall be true without qualification as to materiality) on and as of the date of the Closing with the
same effect as though such representation and warranty had been made on and as of that date without reference to the revised schedule contemplated by the immediately following sentence. Immediately prior to the Closing, and with the Investors’
consent the Company may provide each of the Investors with a new Schedule of Exceptions, updated for such Closing, without prejudice to the condition to closing contained in the immediately preceding sentence. 
  

 20 

 4.2 Performance. Each Warrantor shall have performed and complied in all respects with all
covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing. 
 4.3 Compliance Certificate. The chief executive officer of the Company shall deliver to the Investors at the Closing a certificate certifying that the conditions specified in Sections 4.1 and 4.2
have been fulfilled. 
 4.4 Qualifications and Consents. All authorizations, approvals or permits, if any, of any governmental
authority or regulatory body and all consents and approvals of any third party that are required in connection with the lawful consummation of the transactions provided for herein and in the Related Agreements (including, without limitation, the
lawful issuance and sale of the Securities pursuant to this Agreement) shall be obtained and effective as of the Closing without the imposition of any obligations, liabilities or conditions adverse to the Company or any Investor. Without limiting
the generality of the foregoing, each of the Company’s existing shareholders shall have waived any preemptive right or right of first offer (or any comparable right) any such shareholder may have to purchase any of the Securities. 

4.5 Proceedings and Documents. All corporate and other proceedings in connection with the transactions contemplated by this Agreement and the
Related Agreements at the Closing and all documents incident thereto shall be reasonably satisfactory in form and substance to the Investors’ counsel, and the Investors’ counsel shall have received all such counterpart original and
certified or other copies of such documents as it may reasonably request. 
 4.6 Opinion of Company Counsel. The Investors shall have
received from (i) Conyers, Dill & Pearman, special Cayman Islands counsel for the Company, a legal opinion dated as of the Closing, in the form of Exhibit E; and (ii) Grandall Legal Group, special PRC counsel to the Group,
a legal opinion dated as of the Closing, in the form of Exhibit F. 
 4.7 Board of Directors. The Restated Articles shall have
been duly and validly adopted, shall have become effective at law, and shall reflect that the Board of Directors of the Company shall consist of seven (7) members. The Restated Articles shall also permit the attendance at Board meetings of up
to seven (7) non-voting observers, each Investor having the right to appoint a non-voting observer. As of the Closing, the Board of Directors of the Company shall include Yi Sing CHAN, Guan Yong TIAN and Xiaofeng CAO as nominees of the holders
of Ordinary Shares, Pu ZHAI, as nominee of holders of Series A Shares, Jian Huan ZHU (with his alternate director being Vincent CHAN Chun Hung) and GOH Yin Long (with Tina JU as his alternate director), as nominees of holders of Series B Shares, and
an independent member approved by the Founders, a majority of the Series A Shares, and the Investors. 
 4.8 Registration Rights
Agreement. The Company and each of the other Investors shall have executed and delivered the Registration Rights Agreement. 
 4.9
Shareholders’ Agreement. Each holder of Ordinary Shares listed on Exhibit D-1 (the “Principal Shareholders”) and each of the other Investors shall have executed and delivered the Shareholders’
Agreement. 
  

 21 

 4.10 Officer’s Certificate. The Company’s Secretary shall have delivered to each
Investor a certificate dated as of the Closing and signed by the Secretary certifying, among other things, copies of the Board of Directors and shareholder resolutions approving the transactions contemplated by this Agreement and the Related
Agreements and true and correct copies of the Restated Articles and the By-laws. 
 4.11 No Material Adverse Change. Since the
execution of this Agreement, there shall not have occurred any event or condition which has had, or could reasonably be expected to have, a material adverse change in the business, assets, properties, liabilities or condition of any member of the
Group. 
 4.12 No Litigation. There shall not be any action, suit, proceeding or investigation of or before any governmental authority
pending or threatened (i) with respect to this Agreement, the Related Agreements or any of the transactions contemplated hereby or thereby or (ii) which could reasonably be expected to result in a Material Adverse Effect. 
 4.13 Payment of Expenses. The Company shall have paid all fees and expenses in accordance with Section 7.8 hereof. 
 4.14 Share Certificates. At the Closing, the Company shall have tendered to each Investor a certificate representing shares of Series B Shares in
accordance with Schedule I hereof, all in form and substance reasonably satisfactory to such Investor. 
 4.15 Share Option
Pool. Prior to Closing, the Company’s Board of Directors shall have approved a plan granting or reserving for issuance options to purchase Ordinary Shares, which plan shall be for present or former employees, officers or consultants of the
Company and shall contain upon Closing an amount of reserved Ordinary Shares which, when combined with all other options issued or issuable under any prior or existing plan does not exceed 8% of the Company’s total Ordinary Shares after giving
effect to exercise or conversion of all securities of the Company exercisable for or convertible into Ordinary Shares immediately after the Closing. 
 4.16 Minimum Commitment. The Company shall have received pursuant to this Agreement commitments to purchase Series B Shares in an amount not less than US$10.0 million. 
 4.17 Confidentiality Agreement. A Confidentiality Agreement shall have been duly executed and delivered by each Founder, and each senior manager
and key employee of the Group identified in Schedule VI, and copies of such agreements certified true on behalf of the Company shall have been delivered to the Investors or their counsel. 
 4.18 Compensation Committee. A compensation committee of the Company that, upon Closing, shall be made up of the chief executive officer of the
Company, the nominee to the Board of Directors of the holders of Series A Shares, and the two nominees to the Board of Directors of the holders of Series B Shares shall have been established to formulate and determine on behalf of the Board of
Directors, among other things, the compensation, benefits and remuneration of directors, officers and employees of the Group, the terms of the Company’s share incentive plan and the grant of share options or other equity incentives by the
Company. 
  

 22 

 4.19 Authorized Shares. All previously issued 8% Accumulating Preferred Shares of the Company
shall have been repurchased or redeemed, and cancelled in full. Other than the Ordinary Shares, Series A Shares and Series B Shares specified in Section 2.3, the Company has no other authorized class of share capital. 
 4.20 OpCo Agreements. Additional agreements between OpCo and WFOE or other Group members, pursuant to which WFOE or such other Group members
maintain control over OpCo and derive payments from OpCo, in each case in form and substance satisfactory to the Investors, shall have been executed and certified true copies thereof shall have been delivered to the Investors or their counsel.

 4.21 Due Diligence. A due diligence review of the Group Companies (including but not limited to legal, financial, management,
technology, Intellectual Property, process, licenses and government regulatory due diligence) shall have been completed to the satisfaction of the Investors. 
 4.22 Indemnification Agreement. An indemnification agreement in the form of Exhibit I shall have been duly executed and delivered by the Company in favor of each nominee of the holders of Series A Shares
and Series B Shares to the Board of Directors. 
 4.23 Executive Employment Agreements. Each of Yi Sing CHAN and TIAN Guanyong shall
have entered into a service agreement with the Company in form and substance reasonably satisfactory to the Investors for a term of at least three years, and each of CAO Xiao Feng, YAO Fang and ZHU Hai Guang shall have entered into a service
agreement with the WFOE in form and substance reasonably satisfactory to the Investors for a term of at least three years, and copies of such agreements certified true on behalf of the Company shall have been delivered to the Investors or their
counsel. 
 4.24 Financial Control Policies. The Group shall have adopted and implemented financial control and reporting policies and
procedures satisfactory to the Investors. 
 4.25 Loan. The Warrantors shall have demonstrated to the reasonable satisfaction of the
Investors that they have made best efforts to obtain a renewal or extension of a RMB17,000,000 medium term RMB loan to OpCo by the Bank of Communications, Changning Sub-branch, with a term continuing for at least one year from the date of Closing.

 4.26 Extension of Loan Repayment. Top Result Promotion Limited, as lender under the Loan Agreement dated March 8, 2005, as
supplemented by a supplemental deed dated April 22, 2005 and an Agreement in Respect of the Loan Agreement and Guarantee US$1,500,000 dated September 16, 2005 (the “September Agreement”), shall have agreed in
writing to extend the time for repayment of the first installment due under Clause 3 of the September Agreement, and any other amounts due and payable under the foregoing agreements, to a date that the Investors reasonably consider to be adequate.

 If at the Closing the Company fails to tender to the Investors the documents specified herein which are required to be delivered to the
Investors at the Closing or if at the Closing any of the conditions specified in this Section 4 have not been fulfilled to each Investor’s satisfaction, or waived by each Investor, such Investor shall, at its election, be relieved
of all further obligations under this Agreement, without prejudice to any accrued rights it may have. 
  

 23 

 5. Conditions of the Company’s Obligations at Closing. 
 The obligations of the Company under Section 1 of this Agreement are subject to the fulfillment, or waiver by the Company, of each of the
following conditions on or before the Closing. 
 5.1 Representations and Warranties True at Closing. The representations and
warranties of the Investors contained in Section 3 hereof shall be true in all material respects on and as of the date of the Closing with the same effect as though said representations and warranties had been made on and as of that
date. 
 5.2 Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body that
are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective as of the date of the Closing; provided that Company shall have the benefit of reliance upon this
condition only if the Warrantors have made best efforts, to the satisfaction of the Investors, to obtain all such necessary authorizations, approvals or permits. 
 5.3 Covenants. All covenants, agreements and conditions contained in this Agreement to be performed by the Investors on or prior to the date of the Closing shall have been performed or complied with.

 5.4 Registration Rights Agreement. Each Investor shall have executed and delivered the Registration Rights Agreement. 

5.5 Shareholders’ Agreement. Each Investor shall have executed and delivered the Shareholders’ Agreement. 
 6. Affirmative Covenants of the Group. 
 Each
Group Company hereby covenants and agrees with the Investors as follows: 
 6.1 Accounting and Reserves. It shall maintain a standard
and uniform system of accounting and shall keep proper books and records and accounts in which full, true and correct entries shall be made of its transactions, all in accordance with generally accepted accounting principles applied on a consistent
basis through all periods, and shall set aside on such books for each fiscal year all such proper reserves for depreciation, obsolescence, amortization, bad debts and other purposes in connection with its operations as are required by such
principles so applied. 
 6.2 Payment of Taxes and Claims. It shall pay and discharge promptly all lawful taxes, assessments and
governmental charges or levies imposed upon it or upon its income or profits or upon any of its properties, real, personal or mixed, before the same shall become delinquent, as well as all lawful claims for labor, materials and supplies which, if
unpaid, would by law become a lien or charge upon its properties; provided that if both of the following 

  

 24 

 
conditions are met in any instance, it shall not be obligated, to pay or discharge, or to cause to be paid or discharged, such tax, assessment, charge, levy
or claim: (i) if and for so long as it is contesting in good faith by appropriate proceedings the amount, applicability or validity thereof, and (ii) if it has set aside on its books reserves deemed by it in accordance with generally
accepted accounting principles applicable to it to be adequate with respect to such tax, assessment, charge, levy or claim. 
 6.3
Availability of Ordinary Shares for Conversion. The Company shall at all times reserve and keep available out of its authorized but unissued Ordinary Shares, such number of its duly authorized Ordinary Shares as shall be sufficient to effect
the conversion of the Series B Shares. If at any time the number of authorized but unissued Ordinary Shares shall not be sufficient to effect the conversion of the Series B Shares, or otherwise comply with the terms of this Agreement or any Related
Agreement, the Company shall forthwith take such corporate action as may be necessary to increase its authorized but unissued Ordinary Shares to such number of shares as shall be sufficient for such purposes. 
 6.4 Governing Instruments. The Company shall not amend the Restated Articles in any manner adverse to the rights of the holders of the Series B
Shares. 
 6.5 Use of Proceeds. The Company shall use the entire proceeds (less reasonable expenses agreed by the Investors) from the
sale of the Series B Shares solely for the following purposes or otherwise in accordance with the Business Plan, and in accordance with any control procedures approved by the Investors from time to time: 
  

				
	 Repurchase of Accumulating Preferred Shares
	  	$	1,870,399
	 Payment of fees to financial advisors to the Company
	  	$	300,000
	 Payment of legal counsel, and legal and financial due diligence fees to Series B Investors or their advisors
	  	$	85,000
	 Payment of legal fees to Company counsel with respect to Series B Shares financing
	  	$	100,000
	 Payment of legal fees to Company counsel with respect to Series A Shares financing
	  	$	100,000
	 Reimbursement of seven (7) directors of the Company of up to $20,000 per director
	  	Up to $	140,000
	 Capital expenditure as set forth in Business Plan with respect to approximately 300 new site installations
	  	$	4,500,000

 Save as specifically provided in this Agreement, no Group Company shall use any proceeds for
repayment of any debt or for the repurchase, redemption or cancellation of any securities issued by any Group Company. 
 6.6 Visa
Contract. The OpCo shall execute a binding advertising contract with Visa International Service Association or its affiliate(s) on the usual terms of business of Visa International Service Association or such affiliate(s) within two months of
Closing. 
  

 25 

 6.7 Bank Signatories. The bank account of the Company into which the proceeds from the sale of the
Series B Shares hereunder are shall be deposited into a bank account in Hong Kong (the “Main Account”). The Main Account shall only be jointly operated, as at and after Closing, only by the then chief executive officer of the
Company and a director of the Company appointed by JAFCO (the “Main Account Signatories”). The amount of each transfer of funds out of the Main Account shall be at least US$250,000 (or if transferring all the cash remaining
in the Main Account, any lesser amount representing the balance of the Main Account at that time) and each such transfer shall require the joint signatures of the Main Account Signatories. 
 6.8 Registration of Media One Player. The Warrantors shall cause, within 60 days of the Closing, the Media One CGEN Electronic Player Control
Software to be registered in the name of WFOE. 
 7. Miscellaneous Provisions. 
 7.1 Inconsistent Agreements. The Company shall not, and it shall cause each of its subsidiaries not to, enter into any agreement containing any
provision that would (a) be violated or breached by the exercise or performance by the Company or its subsidiary of any of their respective rights or obligations under this Agreement or any Related Agreement or (b) impair in any material
respect the ability of the Company or any subsidiary to comply with the terms of this Agreement or any Related Agreement. 
 7.2 Survival;
Termination. Subject to the last sentence of this Section 7.2, the warranties, representations and covenants of the Company and the Investors contained in or made pursuant to this Agreement shall survive the execution and delivery of
this Agreement and shall in no way be limited, diminished or affected by any investigation made by or on behalf of the Investors. This Agreement, including the representations, warranties and covenants made herein, will terminate on the closing of a
Qualified Public Offering (as such term is defined in the Restated Articles). 
 7.3 Transfer of Successors and Assigns. The terms and
conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties hereto. This Agreement may not be assigned by any party hereto without the prior written consent of the other parties
to this Agreement; provided, however, that this Agreement may be assigned to any affiliate of an Investor or any subsequent holder of any Securities. Nothing in this Agreement, express or implied, is intended to confer
upon any party other than the parties hereto or their respective permitted successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 7.4 Governing Law and Jurisdiction. It is the intention of the parties that the laws of Hong Kong, as such laws are applied to agreements between
Hong Kong residents entered into and to be performed entirely within Hong Kong, shall govern this Agreement in all respects, whether or not all parties hereto are residents of Hong Kong. Any dispute, controversy or claim arising out of or relating
to this Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved through consultation. Such consultation shall begin immediately after one party hereto has delivered to the other party hereto a written request for
such consultation. If within 30 days following the date on which such notice is given the dispute cannot be resolved, 

  

 26 

 
the dispute shall be submitted to arbitration upon the request of either party with notice to the other. The arbitration shall be conducted in Hong Kong
under the auspices of the Hong Kong International Arbitration Centre (the “Centre”). There shall be one arbitrator. The arbitrator shall be jointly appointed by the disputing parties or, failing which the Secretary-General of
the Centre shall appoint the arbitrator. The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the UNCITRAL Arbitration Rules as administered by the Centre at the time of the arbitration. The arbitrator
shall decide any dispute submitted by the parties to the arbitration strictly in accordance with the substantive laws of Hong Kong and shall not apply any other substantive law. Each party shall cooperate with the other in making full disclosure of
and providing complete access to all information and documents requested by the other in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such party. In the course of arbitration, the Parties
shall continue to implement the terms of this Agreement except (as between the disputing parties) for the matters under arbitration. The award of the arbitration tribunal shall be final and binding upon the disputing parties, and the prevailing
party may apply to a court of competent jurisdiction for enforcement of such award. Either party shall be entitled to seek preliminary injunctive relief from any court of competent jurisdiction pending the constitution of the arbitral tribunal.

 7.5 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. 
 7.6 Titles and Subtitles. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. 
 7.7 Notices.

 (a) All notices, requests, demands and other communications under this Agreement or in connection herewith shall be given to or made upon
(i) the Investors at each such Investors address set forth on Schedule VI with a copy to counsel to such Investor indicated thereon; and (ii) any Warrantor at c/o CGEN Digital Media Company Limited, Suite 3293-94, Tower B, City
Center of Shanghai, No. 100 Zunyi Rd., Shanghai 200051; fax: +86 21 6237 1918, attention: Chief Executive Officer, with a copy to Weil, Gotshal & Manges LLP, 4101 CITIC Square, 1168 Nanjing Rd. (W), Shanghai; fax: +86 21 5292 9166,
attention: David Meredith, Esq. 
 (b) All notices, requests, demands and other communications given or made in accordance with the
provisions of this Agreement shall be in writing, and shall be sent by airmail, return receipt requested, or by facsimile with confirmation of receipt, and shall be deemed to be given or made when receipt is so confirmed. 
 (c) Any party may, by written notice to the Company, alter its address or respondent, and such notice shall be considered to have been given three
(3) days after the airmailing or faxing thereof. 
 7.8 Expenses. Each of the Company and the Investors shall bear their own
expenses incurred with respect to this Agreement, the Related Agreements and the transactions contemplated hereby and thereby; provided, however, that the Company will pay at the Closing 

  

 27 

 
the reasonable out-of-pocket expenses of the Investors, including, without limitation, the reasonable fees and expenses of one firm of counsel to the
Investors, attributable to the negotiation, execution and delivery of this Agreement, the Related Agreements or the transactions contemplated hereby, transaction fees and travel expenses in an amount not exceeding US$85,000; and further provided
that the Company will pay such fees in any event should Closing not take place for reasons attributable to any Warrantor. 
 7.9
Attorneys’ Fees. If any action at law or in equity (including arbitration) is necessary to enforce or interpret the terms of this Agreement or any Related Agreement, the prevailing party shall be entitled to reasonable attorneys’
fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled as determined by such court, equity or arbitration proceeding. 
 7.10 Amendments and Waivers. Any term of this Agreement may be amended only with the written consent of the Company and the Investors. Any amendment or waiver effected in accordance with this
Section 7.10 shall be binding upon each of the Investors and each transferee of the Securities, each future holder of all such securities and the Company. 
 7.11 Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, portions of such provisions, or such provisions in their entirety, to the extent necessary,
shall be severed from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 
 7.12 Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any holder of any of the Securities, upon any
breach or default of the Company under this Agreement shall impair any such right, power or remedy of such holder nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or
default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of
any holder of any breach or default under this Agreement, or any waiver on the part of any holder of any provisions or conditions of this agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing.
All remedies, either under this Agreement or by law or otherwise afforded to any holder shall be cumulative and not alternative. 
 7.13
Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement between the parties hereto pertaining to the subject matter hereof, and any and all other written or oral agreements existing between the
parties hereto are expressly canceled. 
 7.14 Further Assurances. Upon request of any of the Investors, all parties hereto agree to
promptly execute and deliver all such other instruments and take all such other actions as any Investor may reasonably request from time to time in order to effectuate and carry out the purposes, privileges, restrictions, rights and duties of the
parties and the other provisions of this Agreement and the Related Agreements. 
  

 28 

 7.15 Specific Performance. The parties hereby declare that it is impossible to measure in money
the damages that will accrue to a party hereto by reason of a failure to perform any of the obligations under this Agreement and that a breach hereof shall cause irreparable injury and, in addition to any other right or remedy available to the
parties hereto at law or in equity, any injured party hereunder shall be entitled to enforcement by court injunction or specific performance of the obligations of the parties hereunder, without the necessity for posting a bond. Notwithstanding the
foregoing sentence, nothing herein shall be construed as prohibiting any injured party hereunder from also pursuing any other rights or remedies for such breach or threatened breach, including receiving damages and attorneys’ fees. The election
of any remedy shall not be construed as a waiver on the part of any injured party hereunder of any right such party may otherwise have at law or in equity, which rights and remedies shall be cumulative. 
 7.16 Understanding Among Investors. The decision of each Investor to purchase Securities pursuant to this Agreement has been made by such Investor
independently of any other Investor and independently of any statements or opinions as to the condition (financial or otherwise) of the Company that may have been made or given by any other Investor or by any agent or employee of any other Investor.
Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no other Investor will be acting as agent of such Investor in connection with monitoring its
investment hereunder. 
 7.17 Publicity. Except as may be required by applicable law, the Company shall not use the name of, or make
reference to, any Investor or any of its affiliates in any press release or in any public manner without such Investor’s prior written consent. 
 7.18 Confidentiality and Non-Disclosure. 
 (a) Each Investor acknowledges that the Company could be
irreparably damaged if trade secrets concerning the business and affairs of the Company were disclosed to or utilized on behalf of any person. Each of the Investors covenants and agrees to and with the Company that, except as otherwise provided in
this Agreement, it will not, at any time, directly or indirectly, without the prior written consent of the Company, divulge, and will not authorize any of its partners, shareholders, directors, officers, employees or agents to divulge, to any person
any trade secrets if such release is intended for, or may result in, its public dissemination. The foregoing requirements of confidentiality shall not apply to information: (i) that is now or in the future becomes freely available to the public
through no fault of or action by such Investor; (ii) that is in the possession of such Investor or the using or disclosing party prior to the time such information was obtained from the Company or that is independently acquired by such Investor
or the using or disclosing party without the aid, application or use of such other information; (iii) that is obtained by such Investor or the using or disclosing party in good faith without knowledge of any breach of a secrecy arrangement from
a third party; or (iv) that is required to be disclosed by applicable law or order of government agency or self-regulatory body (including, without limitation, the Hong Kong Stock Exchange). 
 (b) Non-Disclosure of Terms. The terms and conditions of this Agreement, the Related Agreements and all exhibits and schedules attached hereto and
thereto (collectively, the “Financing Terms”), including their existence, shall be considered confidential information 

  

 29 

 
and shall not be disclosed by any party hereto to any third party except in accordance with the provisions set forth below; provided that such
confidential information shall not include any information that is in the public domain other than by the breach of the confidentiality obligations hereunder. 
 (c) Press Releases, Etc. Any press release issued by any party hereto or any member of the Group shall not disclose any of the Financing Terms and the final form of such press release shall be approved in
advance in writing by the Investors. No other announcement regarding any of the Financing Terms in a press release, conference, advertisement, announcement, professional or trade publication, mass marketing materials or otherwise to the general
public may be made without each Investor’s prior written consent at its sole discretion. 
 (d) Permitted Disclosures.
Notwithstanding anything in the foregoing to the contrary: 
 (i) any party hereto may disclose any of the Financing Terms to its current or
bona fide prospective investors, directors, officers, employees, shareholders, investment bankers, lenders, accountants, auditors, insurers, business or financial advisors, and attorneys, in each case only where such persons or entities are under
appropriate nondisclosure obligations imposed by professional ethics, law or otherwise; 
 (ii) each Investor (and its fund manager) may,
without disclosing the identities of the other Investors or the Financing Terms of their respective investments in the Company without their or the Company’s consent, disclose such Investor’s investment in the Company to third parties or
to the public at its sole discretion and in relation thereto may use the Company’s logo and trademark (without requiring the Company’s further consent). If it does so, the other parties shall have the right to disclose to third parties any
such information disclosed in a press release or other public announcement by such Investor. 
 (iii) notwithstanding clause
(d) (i) immediately above, each Investor shall have the right to disclose: 
 (A) any information to such Investor’s and/or
its fund manager’s and/or its Affiliate’s legal counsel, fund manager auditor, insurer, accountant, consultant or to an officer, director, general partner, limited partner, its fund manager, shareholder, investor, bona fide potential
investor, counsel or advisor, or employee of such Investor and/or its Affiliate; provided, however, that any such person shall be advised of the confidential nature of the information or are under appropriate non-disclosure obligation
imposed by professional ethics, law or otherwise; 
 (B) any information for fund and inter-fund reporting purposes; 
 (C) any information as required by law, government authorities, exchanges and/or regulatory bodies; and/or 
 (D) any information to bona fide prospective purchasers/investors of any share, security or other interests in the Company, 
  

 30 

 (E) any information contained in press releases or public announcements of the Company pursuant to
Section 7.18(c) above. 
 (iv) the confidentiality obligations set out in this Section 7.18 do not apply to:

 (A) information which was in the public domain or known to the relevant party before it was furnished to it by another party hereto
otherwise than as a result of (i) a breach by that party of this Section 7.18 or (ii) a breach of a confidentiality obligation by a third party discloser, where the breach was actually known to that relevant party; 

(B) information the disclosure of which is necessary in order to comply with any applicable law, the order of any court, the requirements of a stock
exchange or to obtain tax or other clearances or consents from any relevant authority; or 
 (C) information disclosed by any director or
observer of the Company to its appointer or any of its Affiliates or to any person to whom disclosure would be permitted in accordance with the foregoing provisions of this Section 7.18(d). 
 (e) Legally Compelled Disclosure. In the event that any party is requested or becomes legally compelled (including without limitation, pursuant to
securities laws and regulations) to disclose the existence of this Agreement and exhibits and schedules attached to such agreement, or any of the Financing Terms hereof in contravention of the provisions of this Section 7.18, such party
(the “Disclosing Party”) shall provide the other parties (the “Non-Disclosing Parties”) with prompt written notice of that fact and use all reasonable efforts to seek (with the cooperation and
reasonable efforts of the other parties) a protective order, confidential treatment or other appropriate remedy. In such event, the Disclosing Party shall furnish only that portion of the information that is legally required and shall exercise
reasonable efforts to keep confidential such information to the extent reasonably requested by any Non-Disclosing Party. 
 (f)
Notices. All notices required under this section shall be made pursuant to Section 7.7 of this Agreement. 
 (g) This
Section 7.18 constitutes the entire agreement between the parties as to the matter of confidentiality and supersedes any separate nondisclosure agreements executed by the Company with the Investors (and/or their Affiliates) with respect
to the transactions contemplated herein. This Section 7.18 shall survive the termination of this Agreement and the other Related Documents. 
 7.19 JAFCO Rights. Any rights of JAFCO Asia Technology Fund III, a Cayman Islands exempted company (“JAFCO”), under this Agreement may, without prejudice to the rights of JAFCO to
exercise any such rights, be exercised by JAFCO Investment (Asia Pacific) Ltd. (“JIAP”) or any other fund manager of JAFCO or their nominees (“JAFCO Manager”), unless JAFCO has (a) given notice to
the other parties that any such rights cannot be exercised by JIAP or a JAFCO Manager; and (b) not given notice to the other parties that such notice which is given under this Section 7.19 has been revoked. 
  

 31 

 IN WITNESS WHEREOF, the parties hereto have executed this Series B Redeemable Convertible Preferred
Shares Purchase Agreement with the intent and agreement that the same shall be effective as of the day and year first written above. 
  

			
		 	COMPANY:
		
	Address:	 	CGEN DIGITAL MEDIA COMPANY LIMITED
	Suite 3293-94, Tower B, City Center of Shanghai	 	
	 No. 100 Zunyi Rd.
 Shanghai 200051, P.R.
China
	 	
	Fax: +86 21 6237 1918	 	 /s/

	Attention: CEO	 	 By:
 Title:

		
		 	HK CO:
		
		 	CGEN MEDIA TECHNOLOGY COMPANY LIMITED
		
		 	 /s/

		 	 By:
 Title:

		
		 	WFOE:
		
		 	 CGEN DIGITAL TECHNOLOGY (SHANGHAI) CO., LTD.
 [GRAPHIC APPEARS HERE]

		
		 	 /s/

		 	 By:
 Title:

		
		 	OPCO:
		
		 	 SHANGHAI CGEN DIGITAL MEDIA NETWORK CO., LTD.
 [GRAPHIC APPEARS HERE]

		
		 	 /s/

		 	By:
		 	Title:

	
	FOUNDERS:
	
	 /s/

	Chan Yi Sing (Singapore NRIC No. S1306068A)
	
	 /s/

	 Tian Guanyong (

)
 (PRC ID No. 133031651224065)

	
	 /s/

	 Cao Xiaofeng (

)
 (PRC ID No. 310112197008270052)

	
	 /s/

	 Yao Fang (

)
 (PRC ID No. 310221670521081)

	
	 /s/

	 Zhu Hai Guang (

)
 (PRC ID No. 410423197106070010)

			
	 	 	INVESTORS:
		
	 Address:
 c/o JAFCO Investment (Asia Pacific)
Ltd.
 6 Battery Road
 #42-01
 Singapore 049909
	 	JAFCO ASIA TECHNOLOGY FUND III
		
	 Fax: +65 6221 3690
 Attn: The President
	 	
		
	With a copy to:	 	
		
	 JAFCO Investment (Hong Kong) Ltd
 30/F, Two International
Finance Centre
 8 Finance Street
 Central, Hong
Kong
	 	
		
	 Tel: +852 2536-1960
 Fax: +852 2536-1979
	 	
		
	Attention: General Manager	 	

  

			
	 	 	 /s/

		 	By:
		 	Title:
		
	Address:	 	 TDF CAPITAL CHINA II, LP
 and TDF
CAPITAL ADVISORS, LP

	 Unit 2505, K. WAH Center
 1010 Huaihai Zhong
Road
 Shanghai 200031
 People’s Republic of
China
	 	
		
	Fax: +86 (21) 5404-7557	 	 /s/

	Attention: Ian Goh	 	By:
		 	Title:

			
	Address:	 	HUITUNG INVESTMENTS (BVI) LIMITED
	 Room 39C, No. 18,
 Caoxi North Road,
 Shanghai 200030
 People’s Republic of China
	 	
		
	Fax: +86 (21) 64865181	 	 /s/

	Attention: David Tso	 	By:
		 	Title:
		
	Address:	 	SUMITOMO CORPORATION EQUITY ASIA LIMITED
	 Suite 602, 6th Floor
 One International Finance Centre

 One Harbour View Street
 Central
 Hong Kong
	 	
		
	Fax: +852 22950600	 	 /s/

	Attention: Joe Chang	 	By:
		 	Title:

 Schedule I 
  

									
	 Investor
	  	 Series B
Shares to be
 Purchased
	  	As a
Percentage
of all
Series B	 	 	Total Purchase
Price
	 JAFCO Asia Technology Fund III
	  	35,272,780	  	40	%	 	US$	4,000,000
	 TDF Capital China II, LP
 TDF Capital Advisors, LP
	  	29,592,099
1,271,584	  	35	%	 	US$
US$	3,355,800
144,200
	 Huitung Investments (BVI) Limited
	  	17,636,390	  	20	%	 	US$	2,000,000
	 Sumitomo Corporation Equity Asia Limited
	  	4,409,098	  	5	%	 	US$	500,000
	 Total:
	  	88,181,951	  	100	%	 	US$	10,000,000

 Schedule II 
 Schedule of Exceptions 
 The information and disclosures contained in this Schedule of Exceptions qualify and
limit the representations and warranties of the Warrantors contained in the Share Purchase Agreement and shall be deemed to be representations and warranties as to the facts disclosed. 
 Section 2.3 
 (c): The Related Agreements impose restrictions on transfer of the Company’s shares, as do
certain agreements that were entered into in connection with the issuance and sale of the Series A Shares. See the annex to Section 2.11. The Series A Shares registered in the name of Yi Sing CHAN have not been fully paid. 
 (d): An existing shareholders’ agreement by and among the Company, the holders of Series A Shares and certain individuals will be replaced by the Shareholders’
Agreement, with the exception of share transfer provisions relating specifically to a performance-related adjustment of the purchase price for the Series A Shares, which could be effected by a transfer of shares held for management individuals to
holders of Series A Shares. See the annex to Section 2.11. 
 Section 2.4 
 WFOE has an option agreement in respect of OpCo. See the annex to Section 2.11. 
 (c)(i): US$2.7 million of US$2.9
million registered capital has been paid up. 
 (c)(iii): WFOE is party to a share option agreement relating to the shares of OpCo [and OpCo is party to a
share pledge agreement]. See Section 2.11. 
 Section 2.6 
 Under the Company’s current Amended and Restated Memorandum and Articles of Association, the consent of holders of the Company’s 8% Accumulating Preferred Shares and the Company’s Series A Shares are
required to issue the Series B Shares. Upon the minimum subscription for Series B Shares being raised, the Company will use approximately US$1.7 million of proceeds received in subscription of the Series B Shares to repurchase APS’s and remove
the consent power of such shares, after which the consent of only the holders of Series A Shares will be required. 
 Section 2.9 
 (a)(ii): Except for commercially available, off-the-shelf software. 
 (b):
The WFOE has applied in the PRC for copyright registration for its MediaOne software. 
 Section 2.10 
 A Group member had a contract with Media Nation for Media Nation to act as sales agent, which contract has been terminated. The Group currently uses sales agents who have
non-exclusive arrangements with the Group to market and sell its products. 

 Section 2.11: Scheduled Contracts 
 Please see attached annex of contracts. 
 The Company has entered into agreements and undertakings with existing
shareholders or their affiliates. See the annex to this Section 2.11. 
 Section 2.12 
 The Company incurred advisory fees of US$[        ] to Dragonrise Capital Group in connection with the sale of the Series B
Shares. 
 Section 2.13 
 Please see the Service
Agreement between the WFOE and the PRC company identified in the annex relating to Section 2.11. 
 OpCo licenses software and IP from Shanghai CGEN
Info. Systems Co., Ltd., a company affiliated with shareholders and the Chairman of the Company. 
 A liability for approximately US$1.5 million was
guaranteed by OpCo and was discharged pursuant to an Agreement in Respect of the Loan Agreement and Guarantee dated September 16, 2005. 
 The equity
interests in OpCo are owned by the spouse of the Chairman of the Company, and 3 other individuals employed by members of the Company’s Group. 
 Section 2.15 
 The minute books of the Company are materially complete and record all material transactions of the Company and its
Subsidiaries. 
 Section 2.16 
 The Company has
leased office space in the ordinary course of business on customary terms and conditions. OpCo licenses software and IP from Shanghai CGEN Info. Systems Co., Ltd. 
 A security interest is registered against CGEN HK for a US$1.1 million letter of credit to guarantee a RMB8.25 million loan to OpCo. 
 (b): There
are no such outstanding options, licenses or agreements of any kind that individually or in the aggregate are material to either the Company, any Subsidiary or the Group. 
 Section 2.17 
 A liability for approximately US$1.5 million was guaranteed by OpCo and was discharged pursuant to
an Agreement in Respect of the Loan Agreement and Guarantee dated September 16, 2005. 
 See Section 2.16. 
 Section 2.18 
 Please see Sections 2.11, 2.16 and 2.17.

 (g): Intellectual property was transferred from OpCo to the WFOE. See the annex to Section 2.11. 

 (m): Proceeds from the subscription to Series B will be used to repurchase the APS’s. 
 Section 2.19 
 In accordance with the closing conditions in
Section 4 of this Agreement, the Company expects to approve a share option plan meeting the conditions described in the Agreement. The Company has entered into employment contracts and compensation agreements with Dragonrise and Weil,
Gotshal & Manges LLP. See the annex to Section 2.11. 

 Schedule III 
 Particulars of the Company 
  

							
	Name	  	:	  	CGEN DIGITAL MEDIA COMPANY LIMITED	  	
				
	Place of Incorporation	  	:	  	Cayman Islands	  	
				
	Registration No.	  	:	  	CR-145540	  	
				
	Date of Incorporation	  	:	  	24 February 2005	  	
				
	Registered Address	  	:	  	4th Floor, P.O. Box 2804, George Town, Grand Cayman, Cayman Islands	  	
				
	Authorized Share Capital	  	:	  	1,000,000	  	
				
	Issued Share Capital	  	:	  	1,000,000	  	
				
	Shareholders	  	:	  	See Exhibit D-1	  	
				
	Directors	  	:	  	CHAN Yi Sing, CAO Xiaofeng, TIAN Guanyong and YAO Fang	  	
				
	Company Secretary	  	:	  	N/A	  	
				
	Registered Agent	  	:	  	Offshore Incorporations (Cayman) Limited	  	

 Schedule IV 
 Particulars of the Subsidiaries 
  

									
	Name	  	:	  	CGEN Media Technology Co., Ltd.	  	
				
	Place of Incorporation	  	:	  	Hong Kong	  	
				
	Registration No.	  	:	  	875785	  	
				
	Date of Incorporation	  	:	  	17 December 2003	  	
				
	Registered Address	  	:	  	Unit 1, 6/F, Grand City Plaza, 1-17 Sai Lau Kok Road, Tsuen Wan New Territories, Hong Kong	  	
				
	Authorized Share Capital	  	:	  	HK$10,000	  	
				
	Issued Share Capital	  	:	  	HK$10,000	  	
					
	Shareholders	  	:	  	Name	  	Percentage of Shares held	  	
		  		  	CGEN Digital Media Co., Ltd.	  	100%	  	
				
	Directors	  	:	  	CHAN Yi Sing, TIAN Guan Yong	  	
				
	Company Secretary	  	:	  	CorpiSs Limited	  	

 Schedule IV Continued 
 PRC Wholly Foreign-Owned Enterprise 
  

					
	Name:	  	CGEN Digital Technology (Shanghai) Co., Ltd.	  	
			
	Approval Number:	  	Shangwaizihuzhangduzi Zi (2005) No. 1260	  	
			
	Registration Number:	  	Qiduhupuzong Zi No. 320829 (Pudong)	  	
			
	Nature of Enterprise:	  	WFOE	  	
			
	Place of Incorporation:	  	Room 2207, No. 200 Zhangheng Road, Zhangjiang High-Tech Park, Shanghai	  	
			
	Total Investment:	  	US$5 million	  	
			
	Registered Capital:	  	US$2.9 million	  	
			
	Paid-up Registered Capital:	  	US$2.7 million	  	
			
	Registered Office:	  	Room 2207, No. 200 Zhangheng Road, Zhangjiang High-Tech Park, Shanghai	  	
			
	Business Scope:	  	Design, develop, produce and sell self-produced products, provide relevant technology consulting services regarding design, test and maintenance of computer system integration	  	
			
	Date of Incorporation:	  	29 August 2005	  	
			
	Operating Term:	  	20 Years	  	
			
	Legal Representative:	  	CHAN Yi Sing	  	
			
	General Manager:	  	CHAN Yi Sing	  	
			
	Branches and Subsidiaries:	  	N/A	  	

 List of Shareholders and Percentage of Equity Interest: 
  

							
	 Name of Shareholder
	  	 Contribution (RMB)
	  	 Form of Contribution
	  	Percentage (%)
	 CGEN Media Technology Co., Ltd.
	  		  		  	100
	 TOTAL
	  		  		  	

 Schedule V 
 Leased Property 
 Address: Room 3293-94, Tower B, City Center of Shanghai, No.100 Zunyi Road, Shanghai 200051
China 
 Duration: 15 August 2005 to 14 August 2007 
 Landlord: LONGVIEW ASSETS LIMITED 

 Schedule VI 
 Notice Schedule 
 Sumitomo Corporation Equity Asia Limited 
 Suite 602, 6th Floor 
 One International Finance Centre 
 One Harbour View Street 
 Central 
 Hong Kong 
 Tel: +852 2295 0300 
 Fax: +852 2295 0600 
 Attn: Joe Chang 
 JAFCO Asia Technology Fund III 
 c/o JAFCO Investment (Asia Pacific) Ltd.

 6 Battery Road 
 #42-01 
 Singapore 049909 
 Tel: 
 Fax: +65 6221 3690 
 Attn: The President 
 with a copy to: 
 JAFCO Investment (Hong Kong) Ltd 
 30/F, Two International Finance Centre 
 8 Finance Street 
 Central, Hong Kong 
 Tel: +852 2536 1960 
 Fax: +852 2536 1979 
 Attn: General Manager 
 TDF Capital China II, LP 
 or TDF Capital Advisors, LP 
 Unit 2505, K. WAH Center 
 1010 Huaihai Zhong Road 
 Shanghai 200031 
 People’s Republic of China 

			
	 Tel. No.:
	  	+86 (21) 5467-0500
	 Fax. No.:
	  	+86 (21) 5404-7557

 Attention: Ian Goh 
 Huitung Investments (BVI) Limited 
 Room 39C, No. 18, 
 Caoxi North Road, 
 Shanghai 200030 

 People’s Republic of China 

			
	Tel. No.:	  	+86 (21) 64275896-15
	Fax. No.:	  	+86 (21) 64865181

 Attention: David Tso 

 EXHIBIT A 
 FORM OF AMENDED AND RESTATED MEMORANDUM 
 AND ARTICLES OF ASSOCIATION 

 EXHIBIT B 
 FORM OF REGISTRATION RIGHTS AGREEMENT 

 EXHIBIT C 
 FORM OF SHAREHOLDERS’ AGREEMENT 

 EXHIBIT D-1 
 SHAREHOLDERS AND PERSONS HOLDING OPTIONS, WARRANTS, ETC. PRIOR TO 
 ISSUANCE OF SERIES B SHARES 

  

									
	 Investor
	  	Series B
Preferred
Shares	  	Series A
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares
	 Yi Sing Chan
	  		  	4,853,898	  	97,087,661	  	101,941,559
	 Totnes International Limited
	  		  		  	2,912,339	  	2,912,339
	 ESOP
	  		  		  		  	20,802,966
	 S.I. Technology Venture Capital Limited
	  		  	33,977,284	  		  	33,977,284
	 Sumitomo Corporation Equity Asia Limited
	  		  	9,707,795	  		  	9,707,795
	 Investlink Consulting (China) Ltd.
	  	2,513,186	  		  		  	2,513,186
		  	 	  	 	  	 	  	 
	 Total:
	  	2,513,186	  	48,538,977	  	100,000,000	  	151,052,163
		  	 	  	 	  	 	  	 

 EXHIBIT D-2 
 SHAREHOLDERS AND PERSONS HOLDING OPTIONS, WARRANTS, ETC. ASSUMING 
 ISSUANCE OF SERIES B SHARES 

  

									
	 Investor
	  	Series B
Preferred
Shares	  	Series A
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares
	 Yi Sing Chan
	  		  	4,853,898	  	97,087,661	  	101,941,559
	 Totnes International Limited
	  		  		  	2,912,339	  	2,912,339
	 ESOP
	  		  		  	20,802,966	  	20,802,966
	 S.I. Technology Venture Capital Limited
	  		  	33,977,284	  		  	33,977,284
	 Sumitomo Corporation Equity Asia Limited
	  	4,409,098	  	9,707,795	  		  	14,116,893
	 Investlink Consulting (China) Ltd.
	  	2,513,186	  		  		  	2,513,186
	 JAFCO Asia Technology Fund III
	  	35,272,780	  		  		  	35,272,780
	 TDF Capital China II, LP
	  	29,592,099	  		  		  	29,592,099
	 TDF Capital Advisors, LP
	  	1,271,584	  		  		  	1,271,584
	 Huitung Investments (BVI) Limited
	  	17,636,390	  		  		  	17,636,390
		  	 	  	 	  	 	  	 
	 Total:
	  	90,695,136	  	48,538,977	  	120,802,966	  	260,037,080
		  	 	  	 	  	 	  	 

 EXHIBIT E 
 FORM OF OPINION OF COMPANY’S CAYMAN ISLANDS COUNSEL 

 EXHIBIT F 
 FORM OF OPINION OF COMPANY’S PRC COUNSEL 

 EXHIBIT G 
 FORM OF INTELLECTUAL PROPERTY RIGHTS ASSIGNMENT, 
 NON-COMPETITION AND CONFIDENTIALITY AGREEMENT

 EXHIBIT H 
 BUSINESS PLAN 

 EXHIBIT I 
 FORM OF INDEMNIFICATION AGREEMENTShare Purchase Agreement, dated as of February 10, 2006

 Exhibit 4.6 
 CGEN DIGITAL MEDIA COMPANY LIMITED 
 SERIES B REDEEMABLE CONVERTIBLE PREFERRED SHARES

 PURCHASE AGREEMENT 
 (Sale by the Company of 
 Series B Redeemable Convertible Preferred Shares in 
 Additional Closing for Aggregate Sale Price US$3,802,337) 
 February 10, 2006 

 TABLE OF CONTENTS 
  

							
	 	 	 	  	 	  	Page
	 1.
	 	 Terms of Purchase and Sale
	  	1
				
		 	 1.1
	  	 Restated Articles
	  	1
				
		 	 1.2
	  	 Purchase and Sale of Series B Shares
	  	2
				
		 	 1.3
	  	 The Closing
	  	2
			
	 2.
	 	 Representations and Warranties of the Warrantors
	  	2
				
		 	 2.1
	  	 Organization Good Standing and Qualification
	  	2
				
		 	 2.2
	  	 Authorization
	  	3
				
		 	 2.3
	  	 Capitalization, Share Incentive Plan
	  	3
				
		 	 2.4
	  	 Subsidiaries
	  	4
				
		 	 2.5
	  	 Compliance with Other Instruments
	  	6
				
		 	 2.6
	  	 Consents
	  	6
				
		 	 2.7
	  	 Permits
	  	6
				
		 	 2.8
	  	 Litigation
	  	6
				
		 	 2.9
	  	 Patents and Other Intangible Assets
	  	7
				
		 	 2.10
	  	 Marketing Rights
	  	8
				
		 	 2.11
	  	 Agreements, Action
	  	9
				
		 	 2.12
	  	 Brokers or Finders
	  	10
				
		 	 2.13
	  	 No Conflict of Interest
	  	10
				
		 	 2.14
	  	 Rights of Registration
	  	11
				
		 	 2.15
	  	 Corporate Documents and Minute Books
	  	11
				
		 	 2.16
	  	 Title to Property and Assets
	  	11
				
		 	 2.17
	  	 Financial Statements
	  	12
				
		 	 2.18
	  	 Changes
	  	13
				
		 	 2.19
	  	 Employment Benefit Plans
	  	14
				
		 	 2.20
	  	 Tax, Tax Returns and Payments
	  	14
				
		 	 2.21
	  	 Insurance
	  	15
				
		 	 2.22
	  	 Labor Agreements and Actions
	  	16
				
		 	 2.23
	  	 Environmental and Safety Laws
	  	16
				
		 	 2.24
	  	 No Other Business
	  	16

							
				
		 	 2.25
	  	 Other Representations and Warranties Relating to WFOE and OpCo
	  	16
				
		 	 2.26
	  	 Disclosure and Accuracy of Information
	  	17
				
		 	 2.27
	  	 Reliance
	  	17
				
		 	 2.28
	  	 Warranties Separate and Independent
	  	17
				
		 	 2.29
	  	 Business Plan
	  	17
				
		 	 2.30
	  	 Transactions with Affiliates
	  	18
				
		 	 2.31
	  	 Knowledge
	  	18
			
	 3.
	 	 Representations and Warranties of the Investor
	  	18
				
		 	 3.1
	  	 Authorization
	  	18
				
		 	 3.2
	  	 Purchase Entirely for Own Account
	  	18
				
		 	 3.3
	  	 Investment Experience
	  	19
				
		 	 3.4
	  	 No Public Market
	  	19
				
		 	 3.5
	  	 Compliance with Laws
	  	19
			
	 4.
	 	 Conditions to Investors’ Obligations at Closing
	  	19
				
		 	 4.1
	  	 Accuracy of Representations and Warranties
	  	19
				
		 	 4.2
	  	 Performance
	  	19
				
		 	 4.3
	  	 Compliance Certificate
	  	20
				
		 	 4.4
	  	 Qualifications and Consents
	  	20
				
		 	 4.5
	  	 Proceedings and Documents
	  	20
				
		 	 4.6
	  	 Opinion of Company Counsel
	  	20
				
		 	 4.7
	  	 Board of Directors
	  	20
				
		 	 4.8
	  	 Officer’s Certificate
	  	20
				
		 	 4.9
	  	 No Material Adverse Change
	  	20
				
		 	 4.10
	  	 No Litigation
	  	21
				
		 	 4.11
	  	 Share Certificates
	  	21
				
		 	 4.12
	  	 Share Option Pool
	  	21
				
		 	 4.13
	  	 Confidentiality Agreement
	  	21
				
		 	 4.14
	  	 Compensation Committee
	  	21
				
		 	 4.15
	  	 Authorized Shares
	  	21
				
		 	 4.16
	  	 OpCo Agreements
	  	21
				
		 	 4.17
	  	 Due Diligence
	  	21
				
		 	 4.18
	  	 Indemnification Agreement
	  	21
				
		 	 4.19
	  	 Share Restriction Agreements
	  	21

							
				
		 	 4.20
	  	 Financial Control Policies
	  	22
				
		 	 4.21
	  	 Loan
	  	22
				
		 	 4.22
	  	 Extension of Loan Repayment
	  	22
			
	 5.
	 	 Conditions of the Company’s Obligations at Closing
	  	22
				
		 	 5.1
	  	 Representations and Warranties True at Closing
	  	22
				
		 	 5.2
	  	 Qualifications
	  	22
				
		 	 5.3
	  	 Covenants
	  	22
				
		 	 5.4
	  	 Registration Rights Agreement
	  	23
				
		 	 5.5
	  	 Shareholders’ Agreement
	  	23
			
	 6.
	 	 Affirmative Covenants of the Group
	  	23
				
		 	 6.1
	  	 Accounting and Reserves
	  	23
				
		 	 6.2
	  	 Payment of Taxes and Claims
	  	23
				
		 	 6.3
	  	 Availability of Ordinary Shares for Conversion
	  	23
				
		 	 6.4
	  	 Governing Instruments
	  	23
				
		 	 6.5
	  	 Use of Proceeds
	  	23
				
		 	 6.6
	  	 Visa Contract
	  	24
				
		 	 6.7
	  	 Bank Signatories
	  	24
				
		 	 6.8
	  	 Registration of Media One Player
	  	24
			
	 7.
	 	 Miscellaneous Provisions
	  	24
				
		 	 7.1
	  	 Inconsistent Agreements
	  	24
				
		 	 7.2
	  	 Survival; Termination
	  	24
				
		 	 7.3
	  	 Transfer of Successors and Assigns
	  	25
				
		 	 7.4
	  	 Governing Law and Jurisdiction
	  	25
				
		 	 7.5
	  	 Counterparts
	  	25
				
		 	 7.6
	  	 Titles and Subtitles
	  	25
				
		 	 7.7
	  	 Notices
	  	26
				
		 	 7.8
	  	 Expenses
	  	26
				
		 	 7.9
	  	 Attorneys’ Fees
	  	26
				
		 	 7.10
	  	 Amendments and Waivers
	  	26
				
		 	 7.11
	  	 Severability
	  	26
				
		 	 7.12
	  	 Delays or Omissions
	  	26
				
		 	 7.13
	  	 Entire Agreement
	  	27
				
		 	 7.14
	  	 Further Assurances
	  	27

							
				
		 	 7.15
	  	 Specific Performance
	  	27
				
		 	 7.16
	  	 Understanding Among Investors
	  	27
				
		 	 7.17
	  	 Publicity
	  	27
				
		 	 7.18
	  	 Confidentiality and Non-Disclosure
	  	27

 SCHEDULES AND EXHIBITS 
  

			
	 Designation
	  	 Description

	 Schedule I
	  	 Investors

		
	 Schedule II
	  	 Schedule of Exceptions

		
	 Schedule III
	  	 Particulars of the Company

		
	 Schedule IV
	  	 Particulars of the Subsidiaries

		
	 Schedule V
	  	 Leased Property

		
	 Schedule VI
	  	 Notice Schedule

		
	 Exhibit A
	  	 Form of Amended and Restated Memorandum and Articles of Association

		
	 Exhibit B
	  	 Form of Registration Rights Agreement

		
	 Exhibit C
	  	 Form of Shareholders’ Agreement

		
	 Exhibit D-1
	  	 Shareholders and Persons Holding Options, Warrants, etc. Prior to Issuance of Series B Shares

		
	 Exhibit D-2
	  	 Shareholders and Persons Holding Options, Warrants, etc. Assuming Issuance of Series B Shares

		
	 Exhibit E
	  	 Form of Opinion of Company’s Cayman Islands Counsel

		
	 Exhibit F
	  	 Form of Opinion of Company’s PRC Counsel

		
	 Exhibit G
	  	 Form of Intellectual Property Rights Assignment, Non-Competition and Confidentiality Agreement

		
	 Exhibit H
	  	 Business Plan

		
	 Exhibit I
	  	 Form of Indemnification Agreement

  

 v 

 CGEN DIGITAL MEDIA COMPANY LIMITED 
 SERIES B REDEEMABLE CONVERTIBLE PREFERRED SHARES 
 PURCHASE AGREEMENT 

 THIS SERIES B REDEEMABLE CONVERTIBLE PREFERRED SHARES PURCHASE AGREEMENT (the
“Agreement”) is made and entered into as of the 10th day of February, 2006, by and among CGEN Digital Media Company Limited, an
exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), CGEN Media Technology Company Limited (“HK Co”), CGEN Digital Technology (Shanghai) Co., Ltd.
[GRAPHIC APPEARS HERE] (“WFOE”), a wholly foreign-owned enterprise organized under the laws of the People’s Republic of China (“PRC”), Shanghai CGEN Digital Media Network Co., Ltd.
[GRAPHIC APPEARS HERE], a domestic limited liability company registered in Shanghai, PRC (“OpCo”), Chan Yi Sing (Singapore NRIC No. S1306068A), Tian Guanyong (

) (PRC ID No. 133031651224065), Cao Xiaofeng (

) (PRC ID No. 310112197008270052), Yao Fang (

) (PRC ID No. 310221670521081) and Zhu Hai Guang (

) (PRC ID No. 410423197106070010) (together with Chan Yi Sing, Tian Guanyong (

), Cao Xiaofeng (

) and Yao Fang (

), the “Founders”, and each a “Founder”; and together with the Company, HK Co, WFOE, OpCo and the Founders, the “Warrantors” and each a
“Warrantor”), and each of the other parties listed in Part A of Schedule I hereto identified as an investor (each of whom is referred to as an “Investor”). 
 WHEREAS, the Company desires to sell to the Investors at the Closing (as defined in Section 1.2 below), in accordance with the terms hereof
and for an aggregate cash consideration up to Three Million Eight Hundred Two Thousand Three Hundred Thirty-Seven Dollars (US$3,802,337), up to (i) Thirty-three Million Five Hundred Twenty-nine Thousand Seven Hundred Forty-six
(33,529,746) of its authorized but unissued Series B Redeemable Convertible Preferred Shares, par value US$.000001 per share (the “Series B Shares”), which are convertible into the Company’s ordinary shares, par
value US$.000001 (the “Ordinary Shares” and, together with the Series B Shares, the “Securities”). 
 WHEREAS, subject to the terms and conditions of this Agreement, the Investors desire to purchase the Series B Shares from the Company in the amounts set forth in Part A of Schedule I hereto. 
 IT IS HEREBY AGREED AS FOLLOWS: 
 1. Terms of Purchase
and Sale. 
 1.1 Restated Articles. 
 The Company has adopted an Amended and Restated Memorandum and Articles of Association in the form attached hereto as Exhibit A (the “Restated Articles”). The rights, preferences and
privileges of the Series B Shares are as provided in the Restated Articles. 
  

 1 

 1.2 Purchase and Sale of Series B Shares. 
 Subject to the terms and conditions of this Agreement, each of the Investors agrees, severally and not jointly, to purchase from the Company at the
Closing, and the Company agrees to sell and issue to each of the Investors at the Closing, that number of Series B Shares as is set forth opposite such Investor’s name in Part A of Schedule I with the aggregate amount to be paid by each
Investor for the Series B Shares to be acquired by such Investor being as stated in Part A of Schedule I opposite such Investor’s name. 
 1.3 The Closing. 
 (a) The closing of the sale and purchase of the Series B Shares pursuant to this Agreement shall take
place at the offices of O’Melveny & Myers LLP at 31st Floor, AIG Tower, One Connaught Road, Central, Hong Kong, on or about February 10, 2006, or at such other time and place as the Company and each of the Investors may mutually
agree (the “Closing”). 
 (b) At the Closing, the Company shall deliver to each Investor a certificate representing
that number of the Series B Shares set forth in Part A of Schedule I opposite the name of such Investor against payment of the purchase price therefor (in the amount set forth opposite such Investor’s name in Part A of Schedule I)
by bank check, wire transfer of immediately available funds, or such other form of payment as shall be mutually agreed upon by such Investor and the Company. If, at the Closing, any of the conditions specified in Section 4 of this
Agreement have not been fulfilled, each of the Investors shall, at its election, be relieved of all of its obligations under this Agreement. 
 2.
Representations and Warranties of the Warrantors. 
 Each Warrantor hereby represents and warrants jointly with the other
Warrantors and severally to each Investor that, except as set forth on the Schedule of Exceptions attached hereto as Schedule II (which exceptions shall be deemed to be representations and warranties as if made hereunder), each of the matters
set out in this Section 2 is true and correct as at the date of this Agreement and as at the Closing. 
 2.1 Organization Good
Standing and Qualification. Schedule III sets out the full corporate particulars of the Company. Schedule IV sets out full corporate particulars of each of the subsidiaries of the Company (the
“Subsidiaries”) and Shanghai CGEN Digital Media Network Co., Ltd. The Company, the Subsidiaries and OpCo shall be collectively referred to as the “Group” and each a “Group
Company”, “member of the Group”, or “Group member”. The details of each member of the Group as set out in Schedules III and IV are true and accurate. Each member of the Group
is duly organized, validly existing and in good standing (or equivalent status in the relevant jurisdiction) under, and by virtue of, the laws of the place of its incorporation or establishment and has the requisite corporate power, right and
authority to carry on its business as now conducted and as proposed to be conducted. Each member of the Group is duly qualified to transact business and is in good standing in each jurisdiction in which the failure so to qualify could reasonably be
expected to have a material adverse effect on its, or the Group’s business, operations, operating results, properties, assets, condition, liabilities or ability to perform any of its obligations under any contract or agreement
(“Material Adverse Effect”). 

 2.2 Authorization. Each Warrantor has all requisite corporate power to execute and deliver this
Agreement, to carry out and perform its obligations under this Agreement, to own, lease and operate its properties and to carry on its business as now conducted, and as proposed to be conducted. All corporate action on the part of each Group
Company, and its officers, directors and shareholders necessary for the authorization, execution and delivery of this Agreement, the Restated Articles, the Registration Rights Agreement, the Shareholders’ Agreement, the performance of all
obligations of each Warrantor hereunder and thereunder and the authorization, issuance and delivery of the Securities has been taken or will be taken prior to the Closing, and this Agreement, the Restated Articles and the Related Agreements
constitute valid and legally binding obligations of each Warrantor party hereto or thereto, enforceable against such Warrantor in accordance with their respective terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance, and other laws of general application affecting the rights of creditors generally, as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies, and (ii) to the extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable securities laws. The Series B Shares, when issued in compliance with the provisions of this Agreement,
will be duly authorized, validly issued and will be fully paid and non-assessable and will have the rights, preferences and privileges described in the Restated Articles. The Ordinary Shares issuable upon conversion of the Series B Shares have been
duly authorized, duly and validly reserved and, when issued in compliance with the provisions of this Agreement and the Restated Articles will be duly authorized, validly issued, fully paid and non-assessable. The Securities will be free of any
liens, charges or encumbrances other than those created by or imposed upon the holders thereof through no action of any Warrantor, and the Securities will be free of restrictions on transfer, other than the restrictions on transfer under this
Agreement and the Related Agreements or under applicable securities laws. 
 2.3 Capitalization, Share Incentive Plan. 
 As at the date of this Agreement and immediately prior to Closing, the authorized and issued capital of the Company is as set out in Schedule III
and Exhibit D-1. The authorized capital of the Company consists, or will consist, contemporaneously with the Closing, of: 
 (a)
Preferred Shares. One Hundred Fifty Million (150,000,000) Series B Redeemable Convertible Preferred Shares, and Eighty Million (80,000,000) Series A Redeemable Convertible Preferred Shares, par value US$.000001 per share
(the “Series A Shares”). The rights, privileges and preferences of the Series B Shares and the Series A Shares are as stated in the Restated Articles. Assuming purchase and subscription in full of all Series B Shares
available for purchase and subscription under this Agreement, the share capital of the Company (including without limitation issued shares, shares authorized for issuance and shares issuable upon exercise of authorized optional or convertible
securities) is set forth in the capitalization table in Exhibit D-2. 
 (b) Ordinary Shares. Seven Hundred Million
(700,000,000) Ordinary Shares, par value US$.000001 per share, of which One Hundred Million (100,000,000) are issued and 

 
outstanding, One Hundred Eleven Million (111,000,000) shall be reserved for issuance upon conversion of issued and outstanding Series A Shares and One
Hundred Fifty Million (150,000,000) shall be reserved for issuance upon conversion of issued and outstanding Series B Shares. 
 (c)
Issued Shares. A true and complete list of (x) the Company’s shareholders and their holdings and (y) those Persons (as defined below) holding options, warrants or other rights to purchase any class of the Company’s share
capital (excluding conversion privileges of the Series B Shares and the Series A Shares) and their holdings, prior to the issuance of the Series B Shares purchased hereunder and assuming issuance of all Series B Shares purchased hereunder,
is set forth in Exhibits D-1 and D-2 respectively to this Agreement. All of the issued and outstanding shares of the Company as of the Closing are duly authorized, validly issued, fully paid and non-assessable and were issued in
compliance with applicable securities laws. The Series B Shares have been duly authorized, and when issued, sold, and delivered in accordance with the terms of this Agreement, will be duly and validly issued, fully-paid and non-assessable, will be
issued in compliance with all applicable securities laws, and will be free of any preemption or similar rights or liens, security interest, pledges, claims, restrictions, equities, charges and encumbrances of any nature whatsoever
(“Encumbrances”) other than as contemplated by the Related Agreements. The Ordinary Shares issuable upon the conversion of the Series B Preferred Shares in accordance with the Restated Charter, have been duly authorized, and
upon issuance in connection with such conversion, will be duly and validly issued, fully-paid and non-assessable, will be issued in compliance with all applicable securities laws, and will be free of any preemption or similar rights or Encumbrances
other than as contemplated by the Related Agreements. 
 (d) Voting and Other Agreements. Except for conversion privileges of the
Series B Shares and the Series A Shares, there are no outstanding options, warrants, rights (including conversion or preemptive rights) or agreements, orally or in writing, for the purchase, redemption or acquisition from the Company of any shares
of its share capital. Except as otherwise contemplated herein, the Company is not a party or subject to any agreement or understanding, and, to the Knowledge of the Warrantors, there is no agreement or understanding between any individual
partnership, limited liability company, joint venture, corporation, association trust or any other entity or organization (collectively, a “Person”) that affects or relates to (A) the voting or giving of written consents
with respect to any security of the Company (including, without limitation, any voting agreements, voting trust agreements, shareholder agreements or similar agreements) or the voting by a director of the Company or (B) the sale, transfer or
other disposition with respect to any security of the Company. 
 2.4 Subsidiaries. The Company does not currently own or control,
directly or indirectly, any interest in any other corporation, association or other business entity other than in the Subsidiaries and OpCo. No Persons other than the Company or the WFOE holds any option, warrant or other right to purchase any class
of any share capital of any of the Subsidiaries or OpCo. All of the issued and outstanding shares of each of the Subsidiaries and OpCo are duly authorized, validly issued, fully paid and non-assessable and were issued in compliance with applicable
securities laws. 
 (a) Capitalization of CGEN HK 
 (i). The Company is the sole legal and beneficial shareholder of CGEN Media Technology Co., Ltd., a company organized under the laws of Hong Kong (“CGEN HK”). 

 (ii). There are no outstanding rights of first refusal, preemptive rights or other rights, warrants,
options, conversion privileges, subscriptions, or other agreements or securities, either directly or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel CGEN HK to increase or decrease its authorized or issued
share capital or to issue, repurchase or redeem any of such capital. 
 (b) Capitalization of WFOE. 
 (i). Registered Capital. The registered capital of WFOE has been fully funded by CGEN HK in accordance with the terms of WFOE’s articles of
association. CGEN HK is the sole legal and beneficial holder of all of the equity interest of WFOE. Such capitalization of WFOE and the ownership of WFOE by CGEN HK have been approved by all relevant PRC authorities, which approvals are in full
force and effect and have not lapsed or been revoked. 
 (ii). Other Securities. There are no outstanding rights of first refusal,
preemptive rights, or other rights, warrants, options, conversion privileges, subscriptions, or other rights, agreements or securities, either directly or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel the
WFOE to increase or decrease the WFOE’s registered capital. 
 (c) Capitalization of OpCo. 
 (i). All of the registered capital of OpCo has been paid in full. 
 (ii). GAO Weiming [GRAPHIC APPEARS HERE] holds 49.5 percent of record, CAO Xiaofeng (

) holds 18 percent of record, YAO Fang (

) holds 13.5 percent of record, TIAN Guanyong (

) holds ten percent of record and ZHU Haiguang (

) holds nine percent of record, respectively, of the equity interest in OpCo, as at the date hereof. 
 (iii). The Persons identified in paragraph (ii) are the only Persons with direct or indirect interests in the equity capital of OpCo, and each such Person holds its respective interests in OpCo free and clear of any Encumbrances,
except as provided under the call option agreement dated on or about January 16, 2006 among WFOE, OpCo and the shareholders of OpCo (the “OpCo Call Option”). None of such Persons will transfer, alienate or dispose of any
direct or indirect interest in OpCo or create any Encumbrance over any such interest except as required pursuant to this Agreement or the OpCo Call Option. 
 (iv). Except pursuant to the OpCo Call Option, there are no outstanding rights of first refusal, preemptive rights or other rights, warrants, options, conversion privileges, subscriptions, or other agreements or
securities, either directly or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel OpCo to increase or decrease its registered capital or to issue, repurchase or redeem any of such registered capital or its issued
capital. 

 2.5 Compliance with Other Instruments. No member of the Group is in violation or default of any
provisions of (i) its Articles and Memorandum of Association (or equivalent charter documents) or (ii) any instrument, contract, undertaking, understanding, indenture or agreement to which it is a party or by which it is bound (each a
“Contract”) or of any judgment, order, writ, decree, statute, rule or regulation applicable to such member of the Group, except where any such violation or default could not reasonably be expected to result in (x) the
Group member’s loss of any right granted under any Contract or (y) a Material Adverse Effect. The execution, delivery and performance of this Agreement, the Related Agreements and the consummation of the transactions contemplated hereby
and thereby will not result in any violation, or constitute a default, by any member of the Group under any such Contract, judgment, order, writ, decree, statute, rule or regulation or an event that results in the creation of any lien, charge or
encumbrance upon any assets of any member of the Group whether with or without the passage of time or the giving of notice, or both. 
 2.6
Consents. No consent, approval, license, order or authorization of, or registration, qualification, designation, declaration or filing with, any governmental authority or any party to a Contract or any other third party is required by any
Warrantor in connection with (x) the valid execution and delivery of this Agreement and the Related Agreements, (y) the offer and sale of the Securities or (z) the consummation of the transactions contemplated by this Agreement and
the Related Agreements, except such filings as may be required under applicable securities laws, which filings will be timely filed within the applicable periods therefor. 
 2.7 Permits. Each member of the Group has all franchises, permits, licenses and any similar authority as necessary for the conduct of its business
as now being conducted by it, except for those franchises, permits, licenses or similar authority the failure of which to obtain could not reasonably be expected to have a Material Adverse Effect. No member of the Group is in material default under
any of such franchises, permits, licenses or other similar authority. The execution, delivery and performance of and compliance with this Agreement and Related Agreements and the issuance of the Securities will not result in suspension, revocation,
impairment, forfeiture or non-renewal of any such franchise, permit, license or similar authority that could reasonably be expected to result in a Material Adverse Effect. 
 2.8 Litigation. There is no action, suit, proceeding or investigation pending or, to the Knowledge of each Warrantor, currently threatened against
any member of the Group or any of their respective properties nor to the Knowledge of any Warrantor is there any basis for the foregoing, including, without limitation, any action, suit, proceeding or investigation that questions the validity of
this Agreement or any Related Agreement or any action to be taken in connection herewith or therewith. No member of the Group nor any of their respective properties is a party or subject to the provisions of any order, writ, injunction, judgment or
decree of any court or government agency or instrumentality. There is no action, suit, proceeding or investigation by any member of the Group currently pending or which any member of the Group currently intends to initiate. 

 2.9 Patents and Other Intangible Assets. 
 (a) All patents and patent rights, entity models, trademarks and trademark rights, trade names and trade name rights, service marks and service mark
rights, service names and service name rights, brand names, internet domain names and sub-domains, inventions, processes, formulas, copyrights and copyright rights, trade dress, business and product names, logos, slogans, trade secrets, industrial
models, processes, designs, methodologies, computer programs (including all source codes), license rights to use packaged software and related documentation, technical information, manufacturing, engineering and technical drawings, know-how and all
pending applications for and registrations of patents, entity models, trademarks, service marks, copyrights and internet domain names and sub-domains (collectively, “Intellectual Property”) used in the business or businesses
of any member of the Group: 
 (i) is owned by the Company or relevant member of the Group as the sole legal and beneficial owner, free of
any license or encumbrance in favor of a third party (the “Group’s Intellectual Property”); or 
 (ii) is used
by the Group in accordance with the terms of a current license from the owner of that Intellectual Property (“Licensed IP”). 
 (b) Each of the Group’s Intellectual Property that is material to the business or businesses of any member of the Group is set forth in Schedule 2.9(c). 
 (c) None of the Group’s Intellectual Property has been wrongfully or unlawfully acquired by the Group. Each of the registrations (and applications
therefor) of the Group’s Intellectual Property is valid. Neither any member of the Group nor any other Person has breached or alleged a breach of any of the licenses under the Licensed IP during the six years preceding the date of this
Agreement. The Group’s Intellectual Property, and the validity or subsistence of the Group’s right, title and interest therein, is not the subject of any current, pending or threatened challenge, claim or proceedings, including for
opposition, cancellation, revocation or rectification, and has not during the period of six years prior to Closing been the subject of any challenge, claim or proceeding, and to the Company’s Knowledge there are no facts or matters that might
give rise to any such challenge, claim or proceeding. The Group has taken commercially reasonable efforts to preserve the Group’s Intellectual Property and without limitation, all renewal fees regarding the Group’s Intellectual Property
due on or before Closing have been paid in full. No member of the Group has entered into any agreement, arrangement or understanding (whether legally enforceable or not) for the licensing, or otherwise permitting the use or exploitation, of the
Group’s Intellectual Property or that prevents, restricts or otherwise inhibits the Group’s freedom to use and exploit the Group’s Intellectual Property. To the Knowledge of each Warrantor, none of the Group’s Intellectual
Property is currently being infringed by any third party or has been so infringed during the six-year period preceding Closing and no third party has threatened any such infringement. No third party has, during the two years preceding the date of
this Agreement made, threatened or brought any challenge, claim or proceedings in relation to the Group’s use of the Licensed IP (and to each Warrantor’s Knowledge there are no facts or matters that might give rise to any such challenge,
claim or proceedings). The carrying on of the Group’s business or businesses as presently constituted does not require any licenses or consents from (except for standard end-user agreements with respect to commercially readily available
intellectual property such as “off the shelf” computer software and for Licensed IP), or the making of royalty or similar payments to, any third party, to 

 
the Knowledge of the Warrantors no member of the Group uses or needs to use any processes or is engaged in any activities that infringe any Intellectual
Property belonging to any third party and no member of the Group has within the six years preceding this Agreement used any Intellectual Property in a way that has infringed or infringes the Intellectual Property rights of a third party. No
Warrantor has any Knowledge that any employees of any Group member is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court, that would
interfere with the use of such employees’ best efforts to promote the interest of the Group or that would conflict with the Group’s business as conducted. Neither the execution nor delivery of this Agreement, nor the carrying on of the
Group’s business by the employees of the Group as conducted will, to the Knowledge of each Warrantor, conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or
instrument under which any such employee is now obligated. To the Knowledge of each Warrantor, it is not and will not be necessary to use any inventions of any of employees of any Group member (or persons it currently intends to hire) made prior to
their employment with the Group. Each Founder and each officer or employee of any Group Company who has developed any Intellectual Property in the course of his or her employment or service with the Group has, where necessary, validly assigned to
the Company or the WFOE all rights, title and interest that he or she may have in or to any such Intellectual Property. 
 (d) No member of
the Group has entered into any agreement, other than as set forth on Schedule 2.9(d) and provided to the Investors or their counsel, to indemnify any other person against any charge of infringement or misappropriation of any Group’s
Intellectual Property. 
 (e) Each Group Company has taken all reasonably necessary action to protect and preserve (i) the validity and
enforceability of trade and service marks and associated goodwill included in the Group’s Intellectual Property; (ii) the enforceability of copyrights and the confidentiality, validity and enforceability of pending patent applications
included in the Group’s Intellectual Property; (iii) the validity and enforceability of patents included in the Group’s Intellectual Property; and (iv) the confidentiality and enforceability of trade secrets and the
confidentiality of other proprietary information included in the Group’s Intellectual Property. 
 (f) There is no agreement pursuant to
which any current or former employee or consultant of any Group Company has rights to any part of the Group’s Intellectual Property. 
 (g) Each Founder, and each senior manager and key technical employee of the Group identified in Schedule 2.9(g), has or as of Closing will have executed an Intellectual Property Rights Assignment, Non-Competition and Confidentiality
Agreement substantially in the form of Exhibit G to this Agreement (a “Confidentiality Agreement”). 
 2.10
Marketing Rights. No member of the Group has granted rights to market or sell its products to any other Person and no member of the Group is bound by any agreement that affects any such member of the Group’s exclusive right to market or
sell its products. 

 2.11 Agreements, Action. 
 Save as disclosed in Schedule 2.11, neither the Company nor any member of the Group is a party to or bound by: 
 (a) any note, bond debenture or other evidence of indebtedness, or any Contract, judgment, order, writ, decree, commitment or
understanding under which it has borrowed any money or issued any note, bond, debenture or other evidence of indebtedness, or any mortgage, pledge, security agreement, deed of trust, financing statement or other document granting any lien,
encumbrance or security interest (including liens, encumbrances or security interests upon properties acquired under conditional sales, capital leases and other title retention or security devices), or any guaranty or endorsement (other than
endorsements for collection in the ordinary course of business) of, or other contingent obligations in respect of, indebtedness for borrowed money or other liabilities or obligations of others, in any separate case in excess of US$50,000 in
principal amount or US$100,000 in the aggregate; 
 (b) any Contract, judgment, order, writ, decree, commitment, arrangement
or understanding relating to any joint venture, partnership or sharing of profits or losses with any Person or entity or permitting any Person or entity to use any technology, know-how or proprietary information of the Company; 
 (c) any Contract, instrument, judgment, order, writ, decree, commitment for the future purchase by any member of the Group of any
materials, equipment, services or supplies that (A) involves the payment of more than US$50,000, (B) continues for a period of more than twelve months, (C) by its terms requires the Company to purchase the entire output or services of
a supplier or (D) provides that any supplier will be the exclusive supplier of the Group; 
 (d) any Contract,
instrument, judgment, order, writ or decree for the sale or other disposition by the Group of its assets or properties other than in the ordinary course of business, or for the merger, or consolidation of any member of the Company with any other
Person; 
 (e) any Contract, instrument, judgment, order, writ or decree containing covenants purporting to limit the freedom
of the Group to compete in any line of business or in any geographic area; 
 (f) any Contract, instrument, judgment, order,
writ or decree not elsewhere specifically disclosed pursuant to this Agreement involving the payment or receipt by any member of the Group of more than US$50,000 per year or US$100,000 over the term thereof; 
 (g) any Contract with a consultant which provides for payment during the term of the Contract of more than US$50,000; 
 (h) any Contract with any employee of the Group that provides for payment of US$50,000 or more per annum; 
 (i) any sale or purchase option or similar contract or arrangement affecting any assets owned or used by any Group Company or by which any
Group Company is bound; or 

 (j) any agreements restricting the freedom of any member of the Group to provide and take
goods and services or to manage its own business affairs by such means and from and to such persons as it may from time to time think fit. 
 Other than as required by this Agreement, the Related Agreements, the Restated Charter and the Contracts identified in Section 2.11 of Schedule II, (i) no Group Company has entered into any agreement with, or given
any undertaking or assurance to, any of the existing shareholders of the Company or their affiliates, and (ii) there are no agreements binding on the Company which prohibit or restrict the sale, disposal or transfer of any equity securities (or
any interests therein) owned by the Company. 
 True and complete copies of all Contracts identified in Section 2.11 of
Schedule II (collectively, the “Scheduled Contracts”) have been provided to counsel for the Investors. The Company has not received any notification of any breach, or default under any of the Scheduled Contracts.

 No member of the Group has (i) declared or paid any dividends, or authorized or made any distribution upon or with respect to any
class or series of its share capital, (ii) other than as expressly set forth in the Financial Statements (as defined below in Section 2.17), incurred any indebtedness for money borrowed or incurred any other liabilities individually
in excess of US$500,000 or in excess of US$1,000,000 in the aggregate, (iii) made any loans or advances to any Person or entity other than ordinary advances for travel expenses for employees in the ordinary course of business, or
(iv) sold, exchanged or otherwise disposed of any of its assets or rights other than in the ordinary course of business and at arm’s length. 
 No member of the Group is a party to or bound by any Contract, or subject to any restriction under its Charter or other constitutional documents that will have a Material Adverse Effect. 
 2.12 Brokers or Finders. Except as shown on the Schedule of Exceptions, no member of the Group has incurred, and will not incur, directly or
indirectly, as a result of any action taken by the Company, any liability for brokerage or finders’ fees or agents’ commissions or any similar charges in connection with this Agreement and the Related Agreements. 
 2.13 No Conflict of Interest. Except as described in the Financial Statements, no member of the Group is indebted, directly or indirectly, to any
of its officers, directors or shareholders in any amount whatsoever other than in connection with expenses or advances of expenses incurred in the ordinary course of business. None of the officers, directors or shareholders of any member of the
Group is indebted to such member of the Group, or any other member of the Group or, to each Warrantor’s Knowledge, has any direct or indirect ownership interest in any firm or corporation with which any member of the Group is affiliated or with
which any member of the Group has a business relationship, or any firm or corporation that competes with the Group. No member of the Group is a guarantor or indemnitor of any 

 
indebtedness of any other Person. None of the officers, directors or shareholders of any member of the Group is directly or indirectly interested in any
Contract with a member of the Group. None of the officers, directors or shareholders of any member of the Group or any affiliate of any such Person has had, either directly or indirectly, any interest in (a) any Person that purchases from or
sells, licenses or furnishes to a member of the Group any goods, property, proprietary assets, Intellectual Property or other property rights or services; or (b) any Contract or agreement to which a member of the Group is a party or by which it
may be bound or affected. 
 2.14 Rights of Registration. Except as contemplated in the Registration Rights Agreement, at the time of
Closing no member of the Group will be obligated to grant to any Person any registration rights, including piggyback rights, that are pari passu or senior to the registration rights to be granted pursuant to the Registration Rights Agreement.

 2.15 Corporate Documents and Minute Books. The copy of the minute books of the Company provided to the counsel for the Investors
contains minutes of all meetings of directors (including committees thereof) and shareholders and all actions by written consent without a meeting by the directors and shareholders since the date of incorporation and reflects all actions by the
directors (and any committee of directors) and shareholders with respect to all transactions referred to in such minutes accurately in all material respects. Each Group Company has properly kept all books, records and registers required to be kept
by it under any applicable material laws. Each Group Company has filed or delivered all material returns, particulars, resolutions and other documents required to be filed with or delivered to any governmental authority in respect of such Group
Company. 
 2.16 Title to Property and Assets. (a) Each member of the Group owns its property and assets free and clear of all
mortgages, liens, loans and encumbrances, except such mortgages, encumbrances, loans and liens that arise in the ordinary course of business and do not materially impair such member of the Group’s ownership or use of such property or any
assets. With respect to the property and assets it leases, including the leased property described on Schedule V, the relevant member of the Group is in compliance in all material respects with such leases and, to each Warrantor’s
Knowledge, holds a valid leasehold interest free of any material liens, claims, loans or encumbrances and is in compliance with such leases. 
 (b) Each member of the Group owns or has a valid right to use all its property and assets necessary for its business as now conducted, including the leased property described on Schedule V, and, to Knowledge of each Warrantor,
without any infringement of the rights of others. There are no outstanding options, licenses or agreements of any kind granted by any member of the Group relating to any of its property or assets, nor is any member of the Group bound by or a party
to any options, licenses or agreements of any kind with respect to any of the property or assets of any other Person except, in either case, for standard end-user agreements with respect to commercially readily available intellectual property such
as “off the shelf” computer software and the Licensed IP. 
 (c) Except as would not have a Material Adverse Effect, the assets
owned, possessed or used by the Group comprise all the assets required to enable the Group to carry on its business in the ordinary course. 

 (c) No debt owed to any Group member is more than three months overdue for payment. No Group member has
released any debt on terms permitting the debtor thereunder to pay less than the book value of the debt, and no debt owing to any Group member has been deferred, subordinated or written off or is reasonably believed to be unrecoverable. 

2.17 Financial Statements. (a) The Company has delivered to the Investors its unaudited consolidated financial statements (including
balance sheet and profit and loss statement and statement of cash flows, the “Financial Statements”) as of and for the nine months ended September 30, 2005 (the “Balance Sheet Date”). The
Financial Statements truly and fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein. Except as set forth in the Financial Statements, neither the
Company nor any Subsidiary has any liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business and at arm’s length subsequent to the Balance Sheet Date and (ii) obligations under
contracts and commitments incurred in the ordinary course of business and at arm’s length, which, in both cases, individually or in the aggregate would not have a Material Adverse Effect. 
 (b) The Company has delivered to the Investors the audited financial statements (including balance sheet and profit and loss statement and statement of
cash flows) of OpCo as of and for the nine months ended September 30, 2004, and its unaudited consolidated financial statements (including balance sheet and profit and loss statement and statement of cash flows, as of and for the year ended
September 30, 2005 (the “OpCo Financial Statements”) which truly and fairly present in all material respects the financial condition and operating results of OpCo as of the dates, and for the periods, indicated therein.
Except as set forth in such financial statements, OpCo has no liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business and at arm’s length subsequent to September 30, 2005 and
(ii) obligations under contracts and commitments incurred in the ordinary course of business and at arm’s length, which, in both cases, individually or in the aggregate would not have a Material Adverse Effect. 
 (c) Full disclosure of and adequate provisions for bad and doubtful debts and all liabilities, actual, contingent or otherwise and of all financial
commitments in existence at the Balance Sheet Date have been made in the Financial Statements and the OpCo Financial Statements. 
 (d) The
results shown by the Financial Statements and the OpCo Financial Statements on the Balance Sheet Date have not (save as therein disclosed) been affected by an extraordinary or exceptional or non-recurring item or by any other circumstances rendering
the profits or losses for the period covered by the Financial Statements and the OpCo Financial Statements unusually high or low. 
 (e) The
Financial Statements and the OpCo Financial Statements reserve or provide in full for all Taxes (as defined below) for which the Group was at the Balance Sheet Date liable, and whether or not the Group has or may have any right of reimbursement
against any other Person, the Financial Statements and the OpCo Financial Statements have provided for in full for any contingent or deferred liability to Taxation. 

 (f) None of the Group’s assets has been acquired for any consideration in excess of its net
realizable value at the date of such acquisition or otherwise than by way of a bargain at arm’s length. 
 (g) The rates of depreciation
adopted in the Financial Statements and the OpCo Financial Statements were sufficient for each fixed asset of the Group to be written down to nil by the end of its useful life. 
 (h) The management accounts have been prepared in accordance with the disclosed accounting policies of the Group and on a consistent basis as those used
in the audited accounts and show a fair view of the assets and liabilities, profits and losses of the Group as at and to the date of the management accounts. 
 (i) The Financial Statements and the OpCo Financial Statements have been prepared in accordance with the requirements of the relevant statutes and on a consistent basis. 
 2.18 Changes. For the purposes of this Section 2.18, the Financial Statements shall be deemed to include the OpCo Financial
Statements. Since September 30, 2004, there has not been: 
 (a) any change in the business, assets, properties,
liabilities, condition or operating results of the Group from that reflected in the Financial Statements, except changes in the ordinary course of business that could not result in a Material Adverse Effect; 
 (b) any damage, destruction or loss, whether or not covered by insurance, materially and adversely affecting the business, assets,
properties, liabilities or condition or operating results of the Group; 
 (c) any waiver (or partial waiver) or compromise by
any member of the Group of a valuable right or of a material debt owed to it; 
 (d) any satisfaction or discharge of any
lien, claim or encumbrance or payment of any obligation by any member of the Group, except in the ordinary course of business that is not material to the business, properties or condition of such member of the Group; 
 (e) any material change to a Contract entered into by any member of the Group; 
 (f) any change in any compensation arrangement or agreement with any employee, officer, director, shareholder, consultant or finder of any
member of the Group; 
 (g) any sale, disposition, assignment or transfer of Group’s Intellectual Property; 

(h) any sale, disposition, assignment or transfer of any tangible assets of the Group, except in the ordinary course of business;

 (i) any resignation or termination of employment of any officer or key employee of the
Group and there is no impending resignation or termination of employment of any director, officer or employee of any Group member that, if consummated, is likely to have a Material Adverse Effect; 
 (j) receipt of notice that there has been a loss of, or order cancellation by, any major customer of any member of the Group or
cancellation or discontinuance by any major supplier or service provider of any member of the Group; 
 (k) any mortgage,
pledge, transfer of a security interest in, or lien, created by any member of the Group with respect to any of its properties or assets, except liens for taxes not yet due or payable; 
 (l) any payment, loan, advance or guaranty made by any member of the Group to, or any sale, transfer or lease of any properties or assets
by any member of the Group or any other agreement or arrangement entered into by any member of the Group with or for the benefit of, its employees, officers, directors or shareholders other than travel advances to employees or directors made in the
ordinary course of its business consistent with past practice; 
 (m) any declaration, setting aside or payment or other
distribution in respect to any of the share capital of any member of the Group, or any direct or indirect redemption, purchase or other acquisition of any of such share capital by any member of the Group; 
 (n) any change in the line of business of any member of the Group; 
 (o) any debt, obligation (other than contracts with the Group’s customers in the ordinary course of business), or liability incurred,
assumed or guaranteed by any member of the Group individually in excess of US$500,000; or 
 (p) any arrangement or commitment
by any member of the Group to do any of the above items described in this Section 2.18. 
 2.19 Employment Benefit Plans.
No member of the Group is a party to or bound by any currently effective employment contract, deferred compensation arrangement, bonus plan, incentive plan, profit sharing plan, retirement agreement or other employee or consultant compensation plan
or agreement. No employee of any member of the Group has been granted the right to continued employment by such member of the Group or to any material compensation following termination of employment with such member of the Group. 
 2.20 Tax, Tax Returns and Payments. (a) Each member of the Group has filed or caused to be filed all required Tax Returns (as defined below)
with the appropriate governmental agencies in all jurisdictions in which such Tax Returns are required to be filed by each member of the Group and all Taxes (as defined below) shown on such Tax Returns payable by such entity have been properly
accrued or paid to the extent such Taxes have become due or are being contested in good faith, and for which reserves therefor have been established by the Group in 

 
accordance with generally accepted accounting principles. No member of the Group has executed any waiver or extensions of any statute of limitations on the
assessment or collection of any Tax or with respect to any liability arising therefrom. None of the income Tax Returns for any member of the Group has been audited by any taxing authority. To the Knowledge of each Warrantor, no member of the Group
is or expects to be involved in any dispute in relation to Tax and there is no relevant governmental authority concerned which has investigated or indicated that it intends to investigate the Tax affairs of any member of the Group. For purposes of
Section 2.17 and this Section 2.20, “Taxes” means and includes all forms of tax, levy, duty, charge, impost, fee, deduction or withholding of any nature imposed, levied, collected withheld or assessed
by any governmental authority or other taxing or similar authority in any part of the world and includes (i) any interest, additional tax, penalty or other charge payable or claimed in respect thereof and (ii) any central, provincial or
local taxes, assessments, interest, penalties, deficiencies, fees and other governmental charges or impositions; and “Tax Return” means any central, provincial or local tax return, report, statement and other similar filings
required to be filed by any member of the Group with respect to Taxes. 
 (b) The provisions for taxes in the respective Financial Statements
are sufficient for the payment of all accrued and unpaid applicable taxes of the relevant member of the Group, whether or not assessed or disputed as of the date of each such balance sheet. There have been no examinations or audits of any tax
returns or reports by any applicable governmental authority, except during routine annual inspection of the OpCo and the Subsidiaries incorporated in the PRC by the relevant PRC governmental authorities nor has any such governmental authority
notified any Group member of its intention to do so. Since the Balance Sheet Date, none of the members of the Group has incurred any taxes, assessments or governmental charges other than in the ordinary course of business and each member of the
Group has made adequate provisions on its books of account for all taxes, assessments and governmental charges with respect to its business, properties and operations for such period. No member of the Group has entered into or been engaged in or
been a party to any transaction or series of transactions or scheme or arrangement of which the main or dominant purpose or one of the main or dominant purposes was the avoidance or deferral of or reduction in the liability to tax of such member of
the Group. No tax scheme in effect, as previously applied in the Financial Statements has been illegal under any applicable laws. 
 2.21
Insurance. Each member of the Group has in full force and effect insurance policies in amounts customary for companies similarly situated and nothing has been done or omitted to be done by or on behalf of such member of the Group that would
make any policy of insurance void or voidable or enable the insurers to avoid the same and there is no claim outstanding under any such policy and to the Knowledge of each Warrantor there are no circumstances likely to give rise to such a claim or
result in an increased rate of premium. All information furnished in obtaining or renewing the insurance policies of any member of the Group was accurate in all material respects when given and any change in that information required to be given was
correctly given in all material respects. No member of the Group is in default under any of these policies or suffered any uninsured losses or waived any rights of material or substantial value or allowed any insurances to lapse. No Group member has
been refused any insurance coverage sought or applied for, and the Company has not been notified in writing that it will be unable to renew its existing insurance coverage. 

 2.22 Labor Agreements and Actions. No member of the Group is bound by or subject to any written or
oral, express or implied, contract, commitment or arrangement (including, without limitation, collective bargaining agreements) with any labor union, and no labor union has requested or, to the Knowledge of each Warrantor, has sought to represent
any of the employees, representatives or agents of any member of the Group. There is no strike or other labor dispute involving any member of the Group pending, or to the Knowledge of each Warrantor, threatened, that could reasonably be expected to
have a Material Adverse Effect. Each member of the Group has complied in all material respects with all applicable laws related to employment. No member of the Group has engaged in any unfair labor practice that could reasonably be expected to
result in a Material Adverse Effect. No member of the Group has a present intention to terminate the employment of any officer or key employee, or any group of key employees. 
 2.23 Environmental and Safety Laws. To each Warrantor’s Knowledge, no member of the Group is in violation in any material respect with any
applicable statute, law or regulation relating to the environment or occupational health and safety that would have a material adverse effect on its employees, and to the Knowledge of each Warrantor, no material expenditures are or will be required
in order to comply with any such existing statute, law or regulation. 
 2.24 No Other Business. The Company was formed solely to
acquire and hold an equity interest in CGEN HK and WFOE (indirectly through its ownership of CGEN HK). Since their formation, the Company and the CGEN HK have not engaged in any business and have not incurred any liability except in the ordinary
course of their business of acquiring and holding the equity interest of CGEN HK and WFOE, respectively. 
 2.25 Other Representations and
Warranties Relating to WFOE and OpCo. 
 (a). The constitutional documents and certificates and related material Contracts
of WFOE and OpCo are valid and have been duly approved or registered (as applicable) by competent PRC governmental authorities. 
 (b). All material consents, approvals, authorizations or licenses requisite under the PRC law for the due and proper establishment and operation of WFOE and OpCo have been duly obtained from the relevant PRC governmental authorities and are
in full force and effect. 
 (c). All filings and registrations with the PRC governmental authorities required in respect of
WFOE and OpCo and its operations including, without limitation, the registrations with Ministry of Commerce, State Administration of Industry and Commerce, State Administration for Foreign Exchange, tax bureau and customs authorities have been duly
completed in accordance with the relevant PRC rules and regulations. 
 (d). Each of WFOE and OpCo has complied with all
relevant PRC laws and regulations regarding the contribution and payment of its registered share capital, the payment schedule of which has been approved by the relevant PRC government authorities. There are no outstanding rights of, or commitments
made by any member of the Group to sell any equity interest in WFOE or OpCo, as applicable. 

 (e). Each of WFOE and OpCo is not in receipt of any letter or notice from any relevant
PRC governmental authority notifying it of revocation of any licenses issued to it for non-compliance or the need for compliance or remedial actions in respect of the activities carried out by WFOE or OpCo as the case may be. 
 (f). Each of WFOE and OpCo has conducted its business activities within the permitted scope of business or has otherwise operated its
business in material compliance with all relevant legal requirements and with all requisite licenses and approvals granted by competent PRC governmental authorities. 
 (g). As to licenses and approvals requisite for the conduct of any part of WFOE’s or OpCo’s, as applicable, business which are
subject to periodic renewal, no Warrantor has any Knowledge of any grounds on which such requisite renewals will not be granted by the relevant PRC governmental authorities. 
 (h). With regard to employment and staff or labor, each of OpCo and WFOE has complied with all applicable PRC laws and regulations in all
material respects, including without limitation, laws and regulations pertaining to welfare funds, social benefits, medical benefits, insurance, retirement benefits, pensions or the like. 
 2.26 Disclosure and Accuracy of Information. Each Warrantor has fully provided the Investors with all the relevant information that the Investors
(or their counsel) have requested for deciding whether to subscribe for the Series B Shares and, to the Knowledge of the Warrantors, all information necessary to enable each Investor to make a fully informed decision as to whether or not to
subscribe for the Series B Shares. All information contained in this Agreement (including the Recitals, Exhibits and the Schedules) and the other documents referred to herein (except such information as provided by the Investors) and the Related
Agreements is true, accurate and complete in all respects and not misleading in any respect. 
 2.27 Reliance. The Warrantors
acknowledge that the Investors have entered into this Agreement in reliance upon the representations and warranties given by them and that they are given with the intention of inducing the Investors to enter into this Agreement. 
 2.28 Warranties Separate and Independent. Each of the warranties is separate and independent and, except as provided in the Schedule of
Exceptions, is not limited: (a) by reference to any other paragraph of Section 2; or (b) by anything in this Agreement, and none of the warranties shall be treated as qualified by any constructive knowledge on the part of the
Investors or any of their respective agents. Each of the warranties is without prejudice to any other warranty and, except where expressly stated otherwise, no provision contained in this Agreement shall govern or limit the extent or application of
any other warranty. A reference made to a particular part of a document when making a disclosure under the Schedule of Exceptions of any matter shall not be treated as a disclosure of the whole document. 
 2.29 Business Plan. The business plan of the Group set forth in Exhibit H (the “Business Plan”), including the
budget, capital expenditure plan and projections set forth therein, has been drawn up based on fair, proper and reasonable assumptions in good faith and in 

 
a professional workmanlike manner and on a realistic basis, after due and careful consideration of all relevant facts and circumstances, and does not give a
misleading indication of the prospects of the Group. There has been no omission from the Business Plan that would make it misleading. 
 2.30
Transactions with Affiliates. Except as required by this Agreement, the Related Agreements, the Restated Charter, the contractual arrangement between WFOE and OpCo or the transactions contemplated hereby or thereby, (i) no director or
senior manager of any member of the Group, no spouse, parent, sibling or children of any such director or senior manager, and no entity controlled by any of the foregoing, has any agreement, understanding, proposed transaction with, indebtedness
owing to, commitments to make loans or to extend or guarantee credit from any member of the Group other than in the ordinary course of business; (ii) the sum of the value of all agreements, understandings, proposed transactions with,
indebtedness owing to, commitments to make loans or to extend or guarantee credit by all members of the Group with respect to any director or senior manager of the Group, the spouse, parents, siblings and children of such director or senior manager,
and any entity in which such director, senior manager or such relatives thereof have a direct or indirect ownership interest of not less than 0.1%, do not exceed US$10,000; and (iii) no director or senior manager of any member of the Group, no
spouse, parent, sibling or children of any such director or senior manager, and no entity controlled by any of the foregoing, has any direct or indirect ownership interest in any affiliate of any member of the Group or in any firm or corporation
that competes with any member of the Group. 
 2.31 Knowledge. In this Agreement, “Knowledge” means best
knowledge of the entity to which knowledge is attributed and includes knowledge, information, belief or awareness that it would have if its principal executive and financial officers had made due and diligent enquiries and investigation. 

3. Representations and Warranties of the Investor. 
 Each Investor, severally and not jointly, hereby represents and warrants to the Company as follows: 
 3.1 Authorization. This
Agreement and the Related Agreements, when executed and delivered by such Investor, will each constitute a valid and legally binding obligation of such Investor, enforceable in accordance with its terms, except (i) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors rights generally, and as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (ii) to the extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable securities laws. 
 3.2 Purchase Entirely for Own Account. This Agreement is made with the Investor in reliance upon the Investor’s representation to the
Company, which by the Investor’s execution of this Agreement the Investor hereby confirms, that the Series B Shares to be acquired by the Investor will be acquired for investment for the Investor’s own account, not as a nominee or agent,
and not with a view to the resale or distribution of any part thereof in violation of securities laws. The Investor represents that it has the requisite power and authority to enter into, execute, deliver and perform this Agreement. 

 3.3 Investment Experience. Each Investor represents that such Investor is experienced in
evaluating and investing in private placement transactions of securities of companies in a similar stage of development to the Company and acknowledges that such Investor is able to fend for himself, herself or itself, can bear the economic risk of
such Investor’s investment, and has such knowledge and experience in financial and business matters that such Investor is capable of evaluating the merits and risks of the investment in the Securities. Without prejudice to the representations
and warranties of the Company herein or its obligations hereunder, the Investor has had the opportunity to inquire of the Company and its senior management regarding information the Investor believes is necessary for it to make an informed decision
in purchasing the Securities, has received all information so requested and has had the opportunity to conduct such due diligence review as it has deemed appropriate. 
 3.4 No Public Market. The Investor acknowledges that the Securities must be held indefinitely. The Investor understands that no public market now exists for any of the securities issued by the Company, that the
Company has made no assurances that a public market will ever exist for the Securities. 
 3.5 Compliance with Laws. Such Investor is
satisfied as to the full observance of the securities laws of such Investor’s jurisdiction in connection with any invitation to subscribe for the Series B Shares or any transaction contemplated by this Agreement, including (i) the legal
requirements of such Investor’s jurisdiction for the purchase of the Series B Shares and (ii) any governmental or other consents that may be relevant to the purchase, holding, redemption, sale or transfer of the Securities. Such
Investor’s subscription and payment for, the Securities will not violate any applicable securities laws of such Investor’s jurisdiction. 
 4.
Conditions to Investors’ Obligations at Closing. 
 The obligations of each of the Investors under this Agreement are subject
to the fulfillment, or the waiver by each of the Investors, of the conditions set forth in this Section 4 on or before the Closing. 
 4.1 Accuracy of Representations and Warranties. Each representation and warranty of the Warrantors contained in this Agreement shall be true in all material respects (except that the representations and warranties contained in
Sections 2.1, 2.2 and 2.3 shall be true without qualification as to materiality) on and as of the date of the Closing with the same effect as though such representation and warranty had been made on and as of that date without
reference to the revised schedule contemplated by the immediately following sentence. Immediately prior to the Closing, and with the Investors’ consent the Company may provide each of the Investors with a new Schedule of Exceptions, updated for
such Closing, without prejudice to the condition to closing contained in the immediately preceding sentence. 
 4.2 Performance. Each
Warrantor shall have performed and complied in all respects with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing. 

 4.3 Compliance Certificate. The chief executive officer of the Company shall deliver to the
Investors at the Closing a certificate certifying that the conditions specified in Sections 4.1 and 4.2 have been fulfilled. 
 4.4 Qualifications and Consents. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body and all consents and approvals of any third party that are required in connection with the lawful
consummation of the transactions provided for herein and in the Related Agreements (including, without limitation, the lawful issuance and sale of the Securities pursuant to this Agreement) shall be obtained and effective as of the Closing without
the imposition of any obligations, liabilities or conditions adverse to the Company or any Investor. Without limiting the generality of the foregoing, each of the Company’s existing shareholders shall have waived any preemptive right or right
of first offer (or any comparable right) any such shareholder may have to purchase any of the Securities. 
 4.5 Proceedings and
Documents. All corporate and other proceedings in connection with the transactions contemplated by this Agreement and the Related Agreements at the Closing and all documents incident thereto shall be reasonably satisfactory in form and substance
to the Investors’ counsel, and the Investors’ counsel shall have received all such counterpart original and certified or other copies of such documents as it may reasonably request. 
 4.6 Opinion of Company Counsel. The Investors shall have received from (i) Conyers, Dill & Pearman, special Cayman Islands counsel
for the Company, a legal opinion dated as of the Closing, in the form of Exhibit E; and (ii) Grandall Legal Group, special PRC counsel to the Group, a legal opinion dated as of the Closing, in the form of Exhibit F. 
 4.7 Board of Directors. The Restated Articles shall have been duly and validly adopted, shall have become effective at law, and shall reflect that
the Board of Directors of the Company shall consist of seven (7) members. The Restated Articles shall also permit the attendance at Board meetings of non-voting observers, each Investor having the right to appoint a non-voting observer. As of
the Closing, the Board of Directors of the Company shall include Yi Sing CHAN, Guan Yong TIAN and Xiaofeng CAO as nominees of the holders of Ordinary Shares, Pu ZHAI, as nominee of holders of Series A Shares, Jian Huan ZHU (with his alternate
director being Vincent CHAN Chun Hung) and GOH Yin Long (with Tina JU as his alternate director), as nominees of holders of Series B Shares, and an independent member approved by Redpoint Ventures II, L.P. pending approval of an independent member
approved by the Founders, a majority of the Series A Shares, and the Investors. 
 4.8 Officer’s Certificate. The Company’s
Secretary shall have delivered to each Investor a certificate dated as of the Closing and signed by the Secretary certifying, among other things, copies of the Board of Directors and shareholder resolutions approving the transactions contemplated by
this Agreement and the Related Agreements and true and correct copies of the Restated Articles. 
 4.9 No Material Adverse Change.
Since the execution of this Agreement, there shall not have occurred any event or condition which has had, or could reasonably be expected to have, a material adverse change in the business, assets, properties, liabilities or condition of any member
of the Group. 

 4.10 No Litigation. There shall not be any action, suit, proceeding or investigation of or before
any governmental authority pending or threatened (i) with respect to this Agreement, the Related Agreements or any of the transactions contemplated hereby or thereby or (ii) which could reasonably be expected to result in a Material
Adverse Effect. 
 4.11 Share Certificates. At the Closing, the Company shall have tendered to each Investor a certificate
representing shares of Series B Shares in accordance with Schedule I hereof, all in form and substance reasonably satisfactory to such Investor. 
 4.12 Share Option Pool. Prior to Closing, the Company’s Board of Directors shall have approved a plan granting or reserving for issuance options to purchase Ordinary Shares, which plan shall be for present
or former employees, officers or consultants of the Company and shall contain upon Closing an amount of reserved Ordinary Shares which, when combined with all other options issued or issuable under any prior or existing plan does not exceed 8% of
the Company’s total Ordinary Shares after giving effect to exercise or conversion of all securities of the Company exercisable for or convertible into Ordinary Shares immediately after the Closing. 
 4.13 Confidentiality Agreement. Certified true copies of the Confidentiality Agreements between the Company and each Founder, senior manager and
key employee of the Group identified in Schedule VI, shall have been delivered to the Investors or their counsel. 
 4.14
Compensation Committee. A compensation committee of the Company that, upon Closing, shall be made up of the chief executive officer of the Company, the nominee to the Board of Directors of the holders of Series A Shares, and the two nominees
to the Board of Directors of the holders of Series B Shares shall have been established to formulate and determine on behalf of the Board of Directors, among other things, the compensation, benefits and remuneration of directors, officers and
employees of the Group, the terms of the Company’s share incentive plan and the grant of share options or other equity incentives by the Company. 
 4.15 Authorized Shares. Other than the Ordinary Shares, Series A Shares and Series B Shares specified in Section 2.3, the Company has no other authorized class of share capital. 
 4.16 OpCo Agreements. Certified true copies of agreements between OpCo and WFOE or other Group members, pursuant to which WFOE or such other Group
members maintain control over OpCo and derive payments from OpCo, shall have been delivered to the Investors or their counsel. 
 4.17 Due
Diligence. A due diligence review of the Group Companies (including but not limited to legal, financial, management, technology, Intellectual Property, process, licenses and government regulatory due diligence) shall have been completed to the
satisfaction of the Investors. 
 4.18 Indemnification Agreement. An indemnification agreement in the form of Exhibit I shall
have been duly executed and delivered by the Company in favor of each nominee of the holders of Series A Shares and Series B Shares to the Board of Directors. 
 4.19 Share Restriction Agreements. Each of Yi Sing CHAN and TIAN Guanyong shall have entered into a share restriction agreement with the Company in form and substance 

 
reasonably satisfactory to the Investors for a term of at least three years, and copies of such agreements certified true on behalf of the Company shall have
been delivered to the Investors or their counsel. 
 4.20 Financial Control Policies. The Group shall have adopted and implemented
financial control and reporting policies and procedures satisfactory to the Investors. 
 4.21 Loan. The Warrantors shall have
demonstrated to the reasonable satisfaction of the Investors that they have made best efforts to obtain a renewal or extension of a RMB17,000,000 medium term RMB loan to OpCo by the Bank of Communications, Changning Sub-branch, with a term
continuing for at least one year from January 16, 2006. 
 4.22 Extension of Loan Repayment. Top Result Promotion Limited, as
lender under the Loan Agreement dated March 8, 2005, as supplemented by a supplemental deed dated April 22, 2005 and an Agreement in Respect of the Loan Agreement and Guarantee US$1,500,000 dated September 16, 2005 (the
“September Agreement”), shall have agreed in writing to extend the time for repayment of the first installment due under Clause 3 of the September Agreement, and any other amounts due and payable under the foregoing
agreements, to a date that the Investors reasonably consider to be adequate. 
 If at the Closing the Company fails to tender to the
Investors the documents specified herein which are required to be delivered to the Investors at the Closing or if at the Closing any of the conditions specified in this Section 4 have not been fulfilled to each Investor’s
satisfaction, or waived by each Investor, such Investor shall, at its election, be relieved of all further obligations under this Agreement, without prejudice to any accrued rights it may have. 
 5. Conditions of the Company’s Obligations at Closing. 
 The obligations of the Company under Section 1 of this Agreement are subject to the fulfillment, or waiver by the Company, of each of the following conditions on or before the Closing. 
 5.1 Representations and Warranties True at Closing. The representations and warranties of the Investors contained in Section 3 hereof
shall be true in all material respects on and as of the date of the Closing with the same effect as though said representations and warranties had been made on and as of that date. 
 5.2 Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body that are required in
connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective as of the date of the Closing; provided that Company shall have the benefit of reliance upon this condition only if the
Warrantors have made best efforts, to the satisfaction of the Investors, to obtain all such necessary authorizations, approvals or permits. 
 5.3 Covenants. All covenants, agreements and conditions contained in this Agreement to be performed by the Investors on or prior to the date of the Closing shall have been performed or complied with. 

 5.4 Registration Rights Agreement. Each Investor shall have executed and delivered a deed of
adherence to the Registration Rights Agreement. 
 5.5 Shareholders’ Agreement. Each Investor shall have executed and delivered a
deed of adherence to the Shareholders’ Agreement. 
 6. Affirmative Covenants of the Group. 
 Each Group Company hereby covenants and agrees with the Investors as follows: 
 6.1 Accounting and Reserves. It shall maintain a standard and uniform system of accounting and shall keep proper books and records and accounts in
which full, true and correct entries shall be made of its transactions, all in accordance with generally accepted accounting principles applied on a consistent basis through all periods, and shall set aside on such books for each fiscal year all
such proper reserves for depreciation, obsolescence, amortization, bad debts and other purposes in connection with its operations as are required by such principles so applied. 
 6.2 Payment of Taxes and Claims. It shall pay and discharge promptly all lawful taxes, assessments and governmental charges or levies imposed upon
it or upon its income or profits or upon any of its properties, real, personal or mixed, before the same shall become delinquent, as well as all lawful claims for labor, materials and supplies which, if unpaid, would by law become a lien or charge
upon its properties; provided that if both of the following conditions are met in any instance, it shall not be obligated, to pay or discharge, or to cause to be paid or discharged, such tax, assessment, charge, levy or claim: (i) if and
for so long as it is contesting in good faith by appropriate proceedings the amount, applicability or validity thereof, and (ii) if it has set aside on its books reserves deemed by it in accordance with generally accepted accounting principles
applicable to it to be adequate with respect to such tax, assessment, charge, levy or claim. 
 6.3 Availability of Ordinary Shares for
Conversion. The Company shall at all times reserve and keep available out of its authorized but unissued Ordinary Shares, such number of its duly authorized Ordinary Shares as shall be sufficient to effect the conversion of the Series B Shares.
If at any time the number of authorized but unissued Ordinary Shares shall not be sufficient to effect the conversion of the Series B Shares, or otherwise comply with the terms of this Agreement or any Related Agreement, the Company shall forthwith
take such corporate action as may be necessary to increase its authorized but unissued Ordinary Shares to such number of shares as shall be sufficient for such purposes. 
 6.4 Governing Instruments. The Company shall not amend the Restated Articles in any manner adverse to the rights of the holders of the Series B Shares. 
 6.5 Use of Proceeds. The Company shall use the entire proceeds (less reasonable expenses agreed by the Investors) from the sale of the Series B
Shares solely for the following purposes or otherwise in accordance with the Business Plan, and in accordance with any control procedures approved by the Investors from time to time: 

				
	 Repurchase of Accumulating Preferred Shares
	 	$	1,870,399
	 Payment of fees to financial advisors to the Company
	 	$	300,000
	 Payment of legal counsel, and legal and financial due diligence fees to Series B Investors or their advisors
	 	$	85,000
	 Payment of legal fees to Company counsel with respect to Series B Shares financing
	 	$	100,000
	 Payment of legal fees to Company counsel with respect to Series A Shares financing
	 	$	100,000
	 Reimbursement of seven (7) directors of the Company of up to $20,000 per director
	 	 	Up to $140,000
	 Capital expenditure as set forth in Business Plan with respect to approximately 300 new site installations
	 	$	4,500,000

 Save as specifically provided in this Agreement, no Group Company shall use any proceeds for
repayment of any debt or for the repurchase, redemption or cancellation of any securities issued by any Group Company. 
 6.6 Visa
Contract. The OpCo shall execute a binding advertising contract with Visa International Service Association or its affiliate(s) on the usual terms of business of Visa International Service Association or such affiliate(s) within two months of
Closing. 
 6.7 Bank Signatories. The bank account of the Company into which the proceeds from the sale of the Series B Shares
hereunder are shall be deposited into a bank account in Hong Kong (the “Main Account”). The Main Account shall only be jointly operated, as at and after Closing, only by the then chief executive officer of the Company and a
director of the Company appointed by JAFCO (the “Main Account Signatories”). The amount of each transfer of funds out of the Main Account shall be at least US$250,000 (or if transferring all the cash remaining in the Main
Account, any lesser amount representing the balance of the Main Account at that time) and each such transfer shall require the joint signatures of the Main Account Signatories. 
 6.8 Registration of Media One Player. The Warrantors shall cause, within 60 days of the Closing, the Media One CGEN Electronic Player Control
Software to be registered in the name of WFOE. 
 7. Miscellaneous Provisions. 
 7.1 Inconsistent Agreements. The Company shall not, and it shall cause each of its subsidiaries not to, enter into any agreement containing any
provision that would (a) be violated or breached by the exercise or performance by the Company or its subsidiary of any of their respective rights or obligations under this Agreement or any Related Agreement or (b) impair in any material
respect the ability of the Company or any subsidiary to comply with the terms of this Agreement or any Related Agreement. 
 7.2 Survival;
Termination. Subject to the last sentence of this Section 7.2, the warranties, representations and covenants of the Company and the Investors contained in or made pursuant to this Agreement shall survive the execution and delivery of
this Agreement and shall in no way be limited, diminished or affected by any investigation made by or on behalf of 

 
the Investors. This Agreement, including the representations, warranties and covenants made herein, will terminate on the closing of a Qualified Public
Offering (as such term is defined in the Restated Articles). 
 7.3 Transfer of Successors and Assigns. The terms and conditions of
this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties hereto. This Agreement may not be assigned by any party hereto without the prior written consent of the other parties to this
Agreement; provided, however, that this Agreement may be assigned to any affiliate of an Investor or any subsequent holder of any Securities. Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective permitted successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 7.4 Governing Law and Jurisdiction. It is the intention of the parties that the laws of Hong Kong, as such laws are applied to agreements between
Hong Kong residents entered into and to be performed entirely within Hong Kong, shall govern this Agreement in all respects, whether or not all parties hereto are residents of Hong Kong. Any dispute, controversy or claim arising out of or relating
to this Agreement, or the interpretation, breach, termination or validity hereof, shall be resolved through consultation. Such consultation shall begin immediately after one party hereto has delivered to the other party hereto a written request for
such consultation. If within 30 days following the date on which such notice is given the dispute cannot be resolved, the dispute shall be submitted to arbitration upon the request of either party with notice to the other. The arbitration shall be
conducted in Hong Kong under the auspices of the Hong Kong International Arbitration Centre (the “Centre”). There shall be one arbitrator. The arbitrator shall be jointly appointed by the disputing parties or, failing which
the Secretary-General of the Centre shall appoint the arbitrator. The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the UNCITRAL Arbitration Rules as administered by the Centre at the time of the
arbitration. The arbitrator shall decide any dispute submitted by the parties to the arbitration strictly in accordance with the substantive laws of Hong Kong and shall not apply any other substantive law. Each party shall cooperate with the other
in making full disclosure of and providing complete access to all information and documents requested by the other in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such party. In the course
of arbitration, the Parties shall continue to implement the terms of this Agreement except (as between the disputing parties) for the matters under arbitration. The award of the arbitration tribunal shall be final and binding upon the disputing
parties, and the prevailing party may apply to a court of competent jurisdiction for enforcement of such award. Either party shall be entitled to seek preliminary injunctive relief from any court of competent jurisdiction pending the constitution of
the arbitral tribunal. 
 7.5 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. 
 7.6 Titles and Subtitles. The titles and
subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. 

 7.7 Notices. 
 (a) All notices, requests, demands and other communications under this Agreement or in connection herewith shall be given to or made upon (i) the Investors at each such Investors address set forth on Schedule
VI with a copy to counsel to such Investor indicated thereon; and (ii) any Warrantor at c/o CGEN Digital Media Company Limited, Suite 3293-94, Tower B, City Center of Shanghai, No. 100 Zunyi Rd., Shanghai 200051; fax: +86 21 6237 1918,
attention: Chief Executive Officer, with a copy to Weil, Gotshal & Manges LLP, 4101 CITIC Square, 1168 Nanjing Rd. (W), Shanghai; fax: +86 21 5292 9166, attention: David Meredith, Esq. 
 (b) All notices, requests, demands and other communications given or made in accordance with the provisions of this Agreement shall be in writing, and
shall be sent by airmail, return receipt requested, or by facsimile with confirmation of receipt, and shall be deemed to be given or made when receipt is so confirmed. 
 (c) Any party may, by written notice to the Company, alter its address or respondent, and such notice shall be considered to have been given three (3) days after the airmailing or faxing thereof. 
 7.8 Expenses. Each of the Company and the Investors shall bear their own expenses incurred with respect to this Agreement, the Related Agreements
and the transactions contemplated hereby and thereby. 
 7.9 Attorneys’ Fees. If any action at law or in equity (including
arbitration) is necessary to enforce or interpret the terms of this Agreement or any Related Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to
which such party may be entitled as determined by such court, equity or arbitration proceeding. 
 7.10 Amendments and Waivers. Any
term of this Agreement may be amended only with the written consent of the Company and the Investors. Any amendment or waiver effected in accordance with this Section 7.10 shall be binding upon each of the Investors and each transferee
of the Securities, each future holder of all such securities and the Company. 
 7.11 Severability. If one or more provisions of this
Agreement are held to be unenforceable under applicable law, portions of such provisions, or such provisions in their entirety, to the extent necessary, shall be severed from this Agreement and the balance of the Agreement shall be interpreted as if
such provision were so excluded and shall be enforceable in accordance with its terms. 
 7.12 Delays or Omissions. No delay or
omission to exercise any right, power or remedy accruing to any holder of any of the Securities, upon any breach or default of the Company under this Agreement shall impair any such right, power or remedy of such holder nor shall it be construed to
be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore
or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any holder of any breach or default under this Agreement, or any waiver on the part of any holder of any provisions or conditions of this
agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any holder shall be cumulative and not alternative.

 7.13 Entire Agreement. This Agreement and the documents referred to herein constitute the entire
agreement between the parties hereto pertaining to the subject matter hereof, and any and all other written or oral agreements existing between the parties hereto are expressly canceled. 
 7.14 Further Assurances. Upon request of any of the Investors, all parties hereto agree to promptly execute and deliver all such other instruments
and take all such other actions as any Investor may reasonably request from time to time in order to effectuate and carry out the purposes, privileges, restrictions, rights and duties of the parties and the other provisions of this Agreement and the
Related Agreements. 
 7.15 Specific Performance. The parties hereby declare that it is impossible to measure in money the damages
that will accrue to a party hereto by reason of a failure to perform any of the obligations under this Agreement and that a breach hereof shall cause irreparable injury and, in addition to any other right or remedy available to the parties hereto at
law or in equity, any injured party hereunder shall be entitled to enforcement by court injunction or specific performance of the obligations of the parties hereunder, without the necessity for posting a bond. Notwithstanding the foregoing sentence,
nothing herein shall be construed as prohibiting any injured party hereunder from also pursuing any other rights or remedies for such breach or threatened breach, including receiving damages and attorneys’ fees. The election of any remedy shall
not be construed as a waiver on the part of any injured party hereunder of any right such party may otherwise have at law or in equity, which rights and remedies shall be cumulative. 
 7.16 Understanding Among Investors. The decision of each Investor to purchase Securities pursuant to this Agreement has been made by such Investor
independently of any other Investor and independently of any statements or opinions as to the condition (financial or otherwise) of the Company that may have been made or given by any other Investor or by any agent or employee of any other Investor.
Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no other Investor will be acting as agent of such Investor in connection with monitoring its
investment hereunder. 
 7.17 Publicity. Except as may be required by applicable law, the Company shall not use the name of, or make
reference to, any Investor or any of its affiliates in any press release or in any public manner without such Investor’s prior written consent. 
 7.18 Confidentiality and Non-Disclosure. 
 (a) Each Investor acknowledges that the Company could be
irreparably damaged if trade secrets concerning the business and affairs of the Company were disclosed to or utilized on behalf of any person. Each of the Investors covenants and agrees to and with the Company that, except as otherwise provided in
this Agreement, it will not, at any time, directly or indirectly, without the prior written consent of the Company, divulge, and will not authorize any of its partners, shareholders, directors, officers, employees or agents to divulge, to any person

 
any trade secrets if such release is intended for, or may result in, its public dissemination. The foregoing requirements of confidentiality shall not apply
to information: (i) that is now or in the future becomes freely available to the public through no fault of or action by such Investor; (ii) that is in the possession of such Investor or the using or disclosing party prior to the time such
information was obtained from the Company or that is independently acquired by such Investor or the using or disclosing party without the aid, application or use of such other information; (iii) that is obtained by such Investor or the using or
disclosing party in good faith without knowledge of any breach of a secrecy arrangement from a third party; or (iv) that is required to be disclosed by applicable law or order of government agency or self-regulatory body (including, without
limitation, the Hong Kong Stock Exchange). 
 (b) Non-Disclosure of Terms. The terms and conditions of this Agreement, the Related
Agreements and all exhibits and schedules attached hereto and thereto (collectively, the “Financing Terms”), including their existence, shall be considered confidential information and shall not be disclosed by any party
hereto to any third party except in accordance with the provisions set forth below; provided that such confidential information shall not include any information that is in the public domain other than by the breach of the confidentiality
obligations hereunder. 
 (c) Press Releases, Etc. Any press release issued by any party hereto or any member of the Group shall not
disclose any of the Financing Terms and the final form of such press release shall be approved in advance in writing by the Investors. No other announcement regarding any of the Financing Terms in a press release, conference, advertisement,
announcement, professional or trade publication, mass marketing materials or otherwise to the general public may be made without each Investor’s prior written consent at its sole discretion. 
 (d) Permitted Disclosures. Notwithstanding anything in the foregoing to the contrary: 
 (i) any party hereto may disclose any of the Financing Terms to its current or bona fide prospective investors, directors, officers, employees,
shareholders, investment bankers, lenders, accountants, auditors, insurers, business or financial advisors, and attorneys, in each case only where such persons or entities are under appropriate nondisclosure obligations imposed by professional
ethics, law or otherwise; 
 (ii) each Investor (and its fund manager) may, without disclosing the identities of the other Investors or the
Financing Terms of their respective investments in the Company without their or the Company’s consent, disclose such Investor’s investment in the Company to third parties or to the public at its sole discretion and in relation thereto may
use the Company’s logo and trademark (without requiring the Company’s further consent). If it does so, the other parties shall have the right to disclose to third parties any such information disclosed in a press release or other public
announcement by such Investor. 
 (iii) notwithstanding clause (d) (i) immediately above, each Investor shall have the right to
disclose: 
 (A) any information to such Investor’s and/or its fund manager’s and/or its Affiliate’s legal counsel, fund
manager auditor, insurer, accountant, 

 
consultant or to an officer, director, general partner, limited partner, its fund manager, shareholder, investor, bona fide potential investor, counsel or
advisor, or employee of such Investor and/or its Affiliate; provided, however, that any such person shall be advised of the confidential nature of the information or are under appropriate non-disclosure obligation imposed by
professional ethics, law or otherwise; 
 (B) any information for fund and inter-fund reporting purposes; 
 (C) any information as required by law, government authorities, exchanges and/or regulatory bodies; 
 (D) any information to bona fide prospective purchasers/investors of any share, security or other interests in the Company; and/or 
 (E) any information contained in press releases or public announcements of the Company pursuant to Section 7.18(c) above. 
 (iv) the confidentiality obligations set out in this Section 7.18 do not apply to: 
 (A) information which was in the public domain or known to the relevant party before it was furnished to it by another party hereto otherwise than as a
result of (i) a breach by that party of this Section 7.18 or (ii) a breach of a confidentiality obligation by a third party discloser, where the breach was actually known to that relevant party; 
 (B) information the disclosure of which is necessary in order to comply with any applicable law, the order of any court, the requirements of a stock
exchange or to obtain tax or other clearances or consents from any relevant authority; or 
 (C) information disclosed by any director or
observer of the Company to its appointer or any of its Affiliates or to any person to whom disclosure would be permitted in accordance with the foregoing provisions of this Section 7.18(d). 
 (e) Legally Compelled Disclosure. In the event that any party is requested or becomes legally compelled (including without limitation, pursuant to
securities laws and regulations) to disclose the existence of this Agreement and exhibits and schedules attached to such agreement, or any of the Financing Terms hereof in contravention of the provisions of this Section 7.18, such party
(the “Disclosing Party”) shall provide the other parties (the “Non-Disclosing Parties”) with prompt written notice of that fact and use all reasonable efforts to seek (with the cooperation and
reasonable efforts of the other parties) a protective order, confidential treatment or other appropriate remedy. In such event, the Disclosing Party shall furnish only that portion of the information that is legally required and shall exercise
reasonable efforts to keep confidential such information to the extent reasonably requested by any Non-Disclosing Party. 
 (f)
Notices. All notices required under this section shall be made pursuant to Section 7.7 of this Agreement. 
 (g) This
Section 7.18 constitutes the entire agreement between the parties as 

 
to the matter of confidentiality and supersedes any separate nondisclosure agreements executed by the Company with the Investors (and/or their Affiliates)
with respect to the transactions contemplated herein. This Section 7.18 shall survive the termination of this Agreement and the other Related Documents. 

 IN WITNESS WHEREOF, the parties hereto have executed this Series B Redeemable Convertible Preferred
Shares Purchase Agreement with the intent and agreement that the same shall be effective as of the day and year first written above. 
  

					
	 	 	COMPANY:
		
	 Address:
 Suite 3293-94, Tower B, City Center of Shanghai

	 	CGEN DIGITAL MEDIA COMPANY LIMITED
	No. 100 Zunyi Rd.	 	
	Shanghai 200051, P.R. China	 	
	 Fax: +86 21 6237 1918
 Attention:
CEO
	 	
  

	 	By:	 	
	 	Title:	 	
		
		 	HK CO:
		
		 	CGEN MEDIA TECHNOLOGY COMPANY LIMITED
		
		 	  

		 	By:	 	
		 	Title:	 	
		
		 	WFOE:
		
		 	 CGEN DIGITAL TECHNOLOGY (SHANGHAI) CO., LTD.
 [GRAPHIC APPEARS HERE]

		
		 	  

		 	By:	 	
		 	Title:	 	
		
		 	OPCO:
		
		 	 SHANGHAI CGEN DIGITAL MEDIA NETWORK CO., LTD.
 [GRAPHIC APPEARS HERE]

		
		 	  

		 	By:	 	
		 	Title:	 	

  

 31 

			
		 	FOUNDERS:
		
		 	  

		 	Chan Yi Sing (Singapore NRIC No. S1306068A)
		
		 	  

		 	 Tian Guanyong (

)
 (PRC ID No. 133031651224065)

		
		 	  

		 	 Cao Xiaofeng (

)
 (PRC ID No. 310112197008270052)

		
		 	  

		 	 Yao Fang (

)
 (PRC ID No. 310221670521081)

		
		 	  

		 	 Zhu Hai Guang (

)
 (PRC ID No. 410423197106070010

					
	 	 	INVESTORS:
		
	 Address:
 3000 Sand Hill Rd.
 Building 2, Suite 290
 Menlo Park, CA 94025
	 	 REDPOINT VENTURES II, L.P., by its General Partner
 REDPOINT VENTURES II, LLC
 REDPOINT ASSOCIATES
II, LLC, as Nominee 

		
	 Fax: +1 650 854-5762
 Attn: John L.
Walecka
	 	  
  

		 	By:	 	John L. Walecka
		 	Title:	 	Managing Director
		
	 Address:
 Suite 602, 6th Floor
 One International Finance Centre
 One Harbour View Street
 Central
 Hong Kong
	 	SUMITOMO CORPORATION EQUITY ASIA LIMITED
		
	Fax: +852 22950600	 	  

	Attention: Joe Chang	 	By:	 	
		 	Title:	 	

 Schedule I 
 Part A 
  

									
	 Investor
	  	Series B Shares to be
Purchased pursuant to
Agreement dated
February 10, 2006
	  	As a Percentage
of all Series B	 	 	Total Purchase
Price
	 Redpoint Ventures, L.P.
	  	28,462,521	  	23.39	%	 	US$	3,227,704
	 Redpoint Associates II, LLC
	  	658,127	  	0.54	%	 	US$	74,633
	 Sumitomo Corporation Equity Asia Limited
	  	4,409,098	  	3.62	%	 	US$	500,000

 Part B 
  

									
	 Investor
	  	 Series B Shares
 Purchased on
January 16, 2006
	  	 As a Percentage
 of all Series B
	 	 	Total Purchase
Price
	 JAFCO Asia Technology Fund III
	  	35,272,780	  	28.98	%	 	US$	4,000,000
	 TDF Capital China II, LP
	  	29,592,099	  	24.31	%	 	US$	3,355,800
	 TDF Capital Advisors, LP
	  	1,271,584	  	1.05	%	 	US$	144,200
	 Huitung Investments (BVI) Limited
	  	17,636,390	  	14.49	%	 	US$	2,000,000
	 Sumitomo Corporation Equity Asia Limited
	  	4,409,098	  	3.62	%	 	US$	500,000
	 Total of Parts A and B:
	  	121,711,697	  	100	%	 	US$	13,802,337

 Schedule II 
 Schedule of Exceptions 
 The information and disclosures contained in this Schedule of Exceptions qualify and
limit the representations and warranties of the Warrantors contained in the Share Purchase Agreement and shall be deemed to be representations and warranties as to the facts disclosed. 
 Section 2.3 
 (c): The Related Agreements impose restrictions on transfer of the Company’s shares, as do
certain agreements that were entered into in connection with the issuance and sale of the Series A Shares. See the annex to Section 2.11. 
 Section 2.4 
 WFOE has an option agreement in respect of OpCo. See the annex to Section 2.11. 
 (c)(i): US$2.7 million of US$2.9 million registered capital has been paid up. 
 (c)(iii): WFOE is party to a share option agreement relating to the shares of OpCo [and OpCo is party to a share pledge agreement]. See Section 2.11. 
 Section 2.9 
 (a)(ii): Except for commercially available, off-the-shelf software. 
 (b): The WFOE has applied in the PRC for copyright registration for its MediaOne software. 
 Section 2.10 
 A Group member had a contract with Media Nation for Media Nation to act as sales agent, which
contract has been terminated. The Group currently uses sales agents who have non-exclusive arrangements with the Group to market and sell its products. 
 Section 2.11: Scheduled Contracts 
 Please see attached annex of contracts. 
 The Company has entered into agreements and undertakings with existing shareholders or their affiliates. See the annex to this Section 2.11. 
 Section 2.12 
 The Company incurred advisory fees of US$300,000
in cash and US$285,000 in value of Series B Shares to Dragonrise Capital Group in connection with the sale of the Series B Shares. 
 Section 2.13

 Please see the Service Agreement between the WFOE and the PRC company identified in the annex relating to Section 2.11. 

 OpCo licenses software and IP from Shanghai CGEN Info. Systems Co., Ltd., a company affiliated with shareholders and the
Chairman of the Company. 
 A liability for approximately US$1.5 million was guaranteed by OpCo and was discharged pursuant to an Agreement in Respect of the
Loan Agreement and Guarantee dated September 16, 2005. 
 The equity interests in OpCo are owned by the spouse of the Chairman of the Company, and 3
other individuals employed by members of the Company’s Group. 
 Section 2.15 
 The minute books of the Company are materially complete and record all material transactions of the Company and its Subsidiaries. 
 Section 2.16 
 The Company has leased office space in the ordinary course of business on customary terms and conditions. OpCo licenses
software and IP from Shanghai CGEN Info. Systems Co., Ltd. 
 A security interest is registered against CGEN HK for a US$1.1 million letter of credit to
guarantee an RMB8.25 million loan to OpCo. 
 (b): There are no such outstanding options, licenses or agreements of any kind that individually or in the
aggregate are material to any of the Company, any Subsidiary or the Group. 
 Section 2.17 
 A liability for approximately US$1.5 million was guaranteed by OpCo and was discharged pursuant to an Agreement in Respect of the Loan Agreement and Guarantee dated
September 16, 2005. 
 See Section 2.16. 
 Section 2.18 
 Please see Sections 2.11, 2.16 and 2.17. 
 (e): The registration rights agreement and shareholders’ agreement entered into in connection with the issuance and sale of Series A Shares were replaced by the Registration Rights Agreement and
Shareholders’ Agreement. 
 (g): Intellectual property was transferred from OpCo to the WFOE. See the annex to Section 2.11. 
 (m): Proceeds from the subscription to Series B were used to repurchase the APS’s. The Company repurchased 4,853,898 Series A Shares, that were not fully paid, from
Chan Yi Sing for approximately US$5.00. 
 Section 2.19 
 The Company has approved a share option plan meeting the conditions described in the Agreement. The Company has entered into employment contracts with Chan Yi Sing and Tian Guan Yong, and compensation agreements with Dragonrise and Weil,
Gotshal & Manges LLP. See the annex to Section 2.11. 

 Schedule III 
 Particulars of the Company 
  

					
	 Name
	  	:	  	CGEN DIGITAL MEDIA COMPANY LIMITED
			
	 Place of Incorporation
	  	:	  	Cayman Islands
			
	 Registration No.
	  	:	  	CR-145540
			
	 Date of Incorporation
	  	:	  	24 February 2005
			
	 Registered Address
	  	:	  	4th Floor, P.O. Box 2804, George Town, Grand Cayman, Cayman Islands
			
	 Authorised Share Capital
	  	:	  	1,000,000
			
	 Issued Share Capital
	  	:	  	1,000,000
			
	 Shareholders
	  	:	  	See Exhibit D-1
			
	 Directors
	  	:	  	CHAN Yi Sing, CAO Xiaofeng, TIAN Guanyong and YAO Fang
			
	 Company Secretary
	  	:	  	N/A
			
	 Registered Agent
	  	:	  	Offshore Incorporations (Cayman) Limited

 Schedule IV 
 Particulars of the Subsidiaries 
  

							
	 Name
	  	:	  	CGEN Media Technology Co., Ltd.
			
	 Place of Incorporation
	  	:	  	Hong Kong
			
	 Registration No.
	  	:	  	875785
			
	 Date of Incorporation
	  	:	  	17 December 2003
			
	 Registered Address
	  	:	  	Unit 1, 6/F, Grand City Plaza, 1-17 Sai Lau Kok Road, Tsuen Wan New Territories, Hong Kong
			
	 Authorised Share Capital
	  	:	  	HK$10,000
			
	 Issued Share Capital
	  	:	  	HK$10,000
				
	 Shareholders
	  	:	  	Name	  	Percentage of Shares held
				
		  		  	CGEN Digital Media Co., Ltd.	  	100%
			
	 Directors
	  	:	  	CHAN Yi Sing, TIAN Guan Yong
			
	 Company Secretary
	  	:	  	CorpiSs Limited

 Schedule IV Continued 
  

 PRC Wholly Foreign-Owned Enterprise 
  

			
	 Name:
	  	CGEN Digital Technology (Shanghai) Co., Ltd.
		
	 Approval Number:
	  	Shangwaizihuzhangduzi Zi (2005) No. 1260
		
	 Registration Number:
	  	Qiduhupuzong Zi No. 320829 (Pudong)
		
	 Nature of Enterprise:
	  	WFOE
		
	 Place of Incorporation:
	  	Room 2207, No. 200 Zhangheng Road, Shanghai
		
	 Total Investment:
	  	US$5 million
		
	 Registered Capital:
	  	US$2.9 million
		
	 Paid-up Registered Capital:
	  	US$2.7 million
		
	 Registered Office:
	  	Room 2207, No. 200 Zhangheng Road, Shanghai
		
	 Business Scope:
	  	Design, develop, produce and sell self-produced products, provide relevant technology consulting services regarding design, test and maintenance of computer system integration
		
	 Date of Incorporation:
	  	29 August 2005
		
	 Operating Term:
	  	20 Years
		
	 Legal Representative:
	  	CHAN Yi Sing
		
	 General Manager:
	  	CHAN Yi Sing
		
	 Branches and Subsidiaries:
	  	N/A

 List of Shareholders and Percentage of Equity Interest: 
  

							
	 Name of Shareholder
	  	 Contribution (RMB)
	  	 Form of Contribution
	  	Percentage (%)
	 CGEN Media Technology Co., Ltd.
	  		  		  	100
				
	 TOTAL
	  		  		  	

 Schedule V 
 Leased Property 
 Address: Room 3293-94, Tower B, City Center of Shanghai, No.100 Zunyi Road, Shanghai 200051
China 
 Duration: 15 August 2005 to 14 August 2007 
 Landlord: LONGVIEW ASSETS LIMITED 

 Schedule VI 
 Notice Schedule 
 Sumitomo Corporation Equity Asia Limited 
 Suite 602, 6th Floor 
 One International Finance Centre 
 One Harbour View Street 
 Central 
 Hong Kong 
 Tel: +852 2295 0300 
 Fax: +852 2295 0600 
 Attn: Joe Chang 
 JAFCO Asia Technology Fund III 
 c/o JAFCO Investment (Asia Pacific) Ltd.

 6 Battery Road 
 #42-01 
 Singapore 049909 
 Tel: 
 Fax: +65 6221 3690 
 Attn: The President 
 with a copy to: 
 JAFCO Investment (Hong Kong) Ltd 
 30/F, Two International Finance Centre 
 8 Finance Street 
 Central, Hong Kong 
 Tel: +852 2536 1960 
 Fax: +852 2536 1979 
 Attn: General Manager 
 TDF Capital China II, LP 
 or TDF Capital Advisors, LP 
 Unit 2505, K. WAH Center 
 1010 Huaihai Zhong Road 
 Shanghai 200031 
 People’s Republic of China 
 Tel. No.: +86 (21) 5467-0500 
 Fax. No.: +86 (21) 5404-7557

 Attention: Ian Goh 
 Huitung Investments (BVI) Limited

 Room 39C, No. 18, 
 Caoxi North Road, 
 Shanghai 200030 

 People’s Republic of China 
 Tel. No.: +86 (21) 64275896-15 
 Fax. No.: +86 (21) 64865181 
 Attention: David Tso 
 Redpoint Ventures 
 3000 Sand Hill Rd. 
 Building 2, Suite 290 
 Menlo Park, CA 94025 
 Tel. No.: +1 650 926 5600 
 Fax: +1 650 854-5762 
 Attention: John L. Walecka 

 EXHIBIT A 
 FORM OF AMENDED AND RESTATED MEMORANDUM 
 AND ARTICLES OF ASSOCIATION 

 EXHIBIT B 
 FORM OF REGISTRATION RIGHTS AGREEMENT 

 EXHIBIT C 
 FORM OF SHAREHOLDERS’ AGREEMENT 

 EXHIBIT D-1 
 SHAREHOLDERS AND PERSONS HOLDING OPTIONS, WARRANTS, ETC. PRIOR TO 
 ISSUANCE OF SERIES B SHARES
PURSUANT TO THIS AGREEMENT 
  

									
	 Investor
	  	Series B
Preferred
Shares	  	Series A
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares
	 Yi Sing Chan
	  		  		  	97,087,661	  	97,087,661
	 Totnes International Limited
	  		  		  	2,912,339	  	2,912,339
	 ESOP
	  		  		  	20,802,966	  	20,802,966
	 S.I. Technology Venture Capital Limited
	  		  	33,977,284	  		  	33,977,284
	 Sumitomo Corporation Equity Asia Limited
	  	4,409,098	  	9,707,795	  		  	14,116,893
	 Investlink Consulting (China) Ltd.
	  	2,513,186	  		  		  	2,513,186
	 JAFCO Asia Technology Fund III
	  	35,272,780	  		  		  	35,272,780
	 TDF Capital China II, LP
	  	29,592,099	  		  		  	29,592,099
	 TDF Capital Advisors, LP
	  	1,271,584	  		  		  	1,271,584
	 Huitung Investments (BVI) Limited
	  	17,636,390	  		  		  	17,636,390
		  	 	  	 	  	 	  	 
	 Total:
	  	90,695,137	  	43,685,079	  	120,802,966	  	255,183,182
		  	 	  	 	  	 	  	 

 EXHIBIT D-2 
 SHAREHOLDERS AND PERSONS HOLDING OPTIONS, WARRANTS, ETC. ASSUMING 
 ISSUANCE OF SERIES B SHARES
PURSUANT TO THIS AGREEMENT 
  

									
	 Investor
	  	Series B
Preferred
Shares	  	Series A
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares
	 Yi Sing Chan
	  		  		  	97,087,661	  	97,087,661
	 Totnes International Limited
	  		  		  	2,912,339	  	2,912,339
	 ESOP
	  		  		  	23,296,518	  	23,296,518
	 S.I. Technology Venture Capital Limited
	  		  	33,977,284	  		  	33,977,284
	 Sumitomo Corporation Equity Asia Limited
	  	8,818,196	  	9,707,795	  		  	18,525,991
	 Investlink Consulting (China) Ltd.
	  	2,513,186	  		  		  	2,513,186
	 JAFCO Asia Technology Fund III
	  	35,272,780	  		  		  	35,272,780
	 TDF Capital China II, LP
	  	29,592,099	  		  		  	29,592,099
	 TDF Capital Advisors, LP
	  	1,271,584	  		  		  	1,271,584
	 Huitung Investments (BVI) Limited
	  	17,636,390	  		  		  	17,636,390
	 Redpoint Ventures II, L.P.
	  	28,462,521	  		  		  	28,462,521
	 Redpoint Associates II, LLC
	  	658,127	  		  		  	658,127
		  	 	  	 	  	 	  	 
	 Total:
	  	124,224,883	  	43,685,079	  	123,296,518	  	291,206,480
		  	 	  	 	  	 	  	 

 EXHIBIT E 
 FORM OF OPINION OF COMPANY’S CAYMAN ISLANDS COUNSEL 

 EXHIBIT F 
 FORM OF OPINION OF COMPANY’S PRC COUNSEL 

 EXHIBIT G 
 FORM OF INTELLECTUAL PROPERTY RIGHTS ASSIGNMENT, 
 NON-COMPETITION AND CONFIDENTIALITY AGREEMENT

 EXHIBIT H 
 BUSINESS PLAN 

 EXHIBIT I 
 FORM OF INDEMNIFICATION AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]